Zakład Bioanalizy i Analizy Leków

Wydział Farmaceutyczny

Zakład Bioanalizy i Analizy Leków

Wydział Farmaceutyczny

Publikacje

  1. Tuzikiewicz A, Wawrzyniak W, Kutner A, Żołek T. Advances in Targeting BCR-ABLT315I Mutation with Imatinib Derivatives and Hybrid Anti-Leukemic Molecules. Molecules. 2026;31(2):1-39.
  2. Priyadarshani H, Mierzejewska-Sinner E, Kózka B, Giebułtowicz J, Urbaniak M. Fungicide effects on diclofenac uptake, translocation and tolerance in zucchini and its endophytes. Science of the Total Environment. 2026;1010:1-12.
  3. Kocur A, Czajkowska A, Moczulski M, Częczek A, Mikaszewska-Sokolewicz M. Rapid, robust LC–MS/MS quantification of cefazolin in whole blood microsamples, plasma, and plasma ultrafiltrate: Analytical method validation and preliminary clinical application in pediatric population. Clinica Chimica Acta. 2026;582:1-10.
  4. Czajkowska A, Mikulska A, Poniewierska M, Suchan A, Sierakowski M, Pawiński T, Kocur A. Novel LC-MS/MS method for measuring methotrexate in high-dose therapy: a comparative study with commercial EMIT and EIA immunoassays. Pharmacological Reports. 2026;78(1):327-340.
  5. Masuda S, Lemaitre F, Barten M, (...), Kunicki P, (...), Pawiński T, (...), Langman L. Everolimus Personalized Therapy: Second Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic Drug Monitoring. 2025;47(1):4-31.
  6. Kunicki P, Stocki A. Determination of Dronedarone and Debutyldronedarone in Human Plasma by HPLC-UV. International Journal of Molecular Sciences. 2025;26(9):1-11.
  7. Kiełczyńska A, Gilant E, Pawiński T, Szlaska I, Buś-Kwaśnik K, Pesta E, Kuc D, Kwiatkowska B. Development and Validation of LC-MS/MS Method for Nintedanib and BIBF 1202 Monitoring in Plasma of Patients with Progressive Pulmonary Fibrosis Associated with Systemic Sclerosis. Pharmaceutics. 2025;17(12):1-17.
  8. Kocur A, Moczulski M, Czajkowska A, Częczek A, Rubik J. The comparison of two volumetric microsampling devices (qDBS and VAMS) for determining ganciclovir levels in capillary blood using the LC-MS/MS technique in pediatric renal transplant recipients. European Journal of Pharmaceutical Sciences. 2025;212:1-13.
  9. Somandi K, Mwale T, Sobiech M, Klejn D, (...), Giebułtowicz J, (...), Luliński P. A Dual-Template Molecularly Imprinted Polymer to Inhibit Quorum Sensing Molecules: Theoretical Design, Optimized Synthesis, Physicochemical Characterization and Preliminary Microbiological Analysis. International Journal of Molecular Sciences. 2025;26(16):1-29.
  10. Osredkar J, Fabjan T, Kumer K, Jekovec-Vrhovšek M, Giebułtowicz J, Bobrowska-Korczak B, Avguštin G, Godnov U. Urinary Uremic Toxin Signatures and the Metabolic Index of Gut Dysfunction (MIGD) in Autism Spectrum Disorder: A Stool-Phenotype-Stratified Analysis. International Journal of Molecular Sciences. 2025;26(21):1-14.
  11. Kocur A, Pawiński T. Microsampling techniques and patient-centric therapeutic drug monitoring of immunosuppressants. Bioanalysis. 2025;17(6):413-427.
  12. Mazurek A, Franczak-Rogowska M, Szeleszczuk Ł. Predicting the Pressure-Induced Isosymmetric Phase Transition of Sulfamic Acid by Applying Periodic Density Functional Theory Calculations. Applied Sciences. 2025;15(8):1-18.
  13. Osredkar J, Fabjan T, Godnov U, Jekovec-Vrhovšek M, Giebułtowicz J, Bobrowska-Korczak B, Avguštin G, Kumer K. Systemic Uremic Toxin Burden in Autism Spectrum Disorder: A Stratified Urinary Metabolite Analysis. International Journal of Molecular Sciences. 2025;26(15):1-14.
  14. Michorowska S, Korytowska-Przybylska N, Piotrowski R, Kułakowski P, Giebułtowicz J. Predictive Role of Metabolic Profiling in Rivaroxaban Efficacy for Thrombus Lysis in Atrial Fibrillation. International Journal of Molecular Sciences. 2025;26(21):1-20.
  15. Żołek T, Kadam M, Nadkarni S, (...), Kutner A. Metabolic Interactions of Side-chain Extended and Unsaturated Vitamin D Analogs with Cytochrome P450 Enzymes: Integrating Theoretical and Experimental Approaches. Biomolecules. 2025;15(9):1-23.
  16. Nałęcz-Jawecki G, Mielniczek J, Wawryniuk M, Giebułtowicz J, Drobniewska A. The Microbial Assay for Risk Assessment (MARA) in the assessment of the antimicrobial activity of ofloxacin and its photoproducts . International Journal of Molecular Sciences. 2025;26(6):1-18.
  17. Tuz D, Smuga D, Pawiński T. Development of Prediction Capabilities for High-Throughput Screening of Physiochemical Properties by Biomimetic Chromatography. Molecules. 2025;30(23):1-23.
  18. Kutner A, Brown G, Kallay E. Special Issue “Novel Strategies in the Development of New Therapies, Drug Substances and Drug Carriers, 3rd Edition”. International Journal of Molecular Sciences. 2025;26(19):1-5.
  19. Davidson J, Jain R, Kizzar T, (...), Michorowska S, (...), Simcox J. Hepatic lipid remodeling in cold exposure uncovers direct regulation of bis(monoacylglycero)phosphate lipids by phospholipase A2 group XV. Cell Metabolism. 2025;37(6):1413-1425.
  20. Kocur A, Olkowski B, Moczulski M, Miszewska-Szyszkowska D, Rostkowska O, Polak K, Korniluk K, Bączkowska T, Durlik M, Pawiński T. Therapeutic Drug Monitoring of Everolimus Using Volumetric Absorptive Microsampling and Quantitative Dried Blood Spot Methods with LC-MS/MS in Adult Solid Organ Transplant Recipients: An Analytical and Clinical Comparative Study. Molecules. 2025;30(15):1-22.
  21. Attanayake R, Mierzejewska-Sinner E, Giebułtowicz J, Kózka B, Kupiec M, Urbaniak M. Aged Turkey manure shapes microbial diversity and antibiotic resistance genes in soil and plants under fertilization. Scientific Reports. 2025;15(1):1-13.
  22. Kunicki P, Grymm M, Pawiński T, Szulczyk D, Waligóra M, Kopeć G. A simple HPLC-UV method for monitoring therapeutic adherence in pulmonary arterial hypertension. Journal of Chromatography B. 2025;1252:1-10.
  23. Haldar S, Petruk A, Marchwicka A, Kutner A, Biernat M, Wołowiec D, Marcinkowska E. Synergy in Immunostimulatory and Pro-Differentiation Effects of Vitamin D Analog and Fludarabine in Acute Myeloid Leukemias. Cells. 2025;14(23):1-28.
  24. Jędreas A, Michorowska S, Drobniewska A, Giebułtowicz J. Environmental Antidepressants Disrupt Metabolic Pathways in Spirostomum ambiguum and Daphnia magna: Insights from LC-MS-Based Metabolomics. Molecules. 2025;30(14):1-16.
  25. Piekoszewska-Ziętek P, Korytowska-Przybylska N, Pańczyk-Tomaszewska M, Olczak-Kowalczyk D. Salivary Interleukin-6 and Interleukin-18 Levels and Their Association with Dental Health in Children with Idiopathic Nephrotic Syndrome. International Journal of Molecular Sciences. 2025;26(7):1-9.
  26. Buczkowska E, Sobiech M, Luliński P, Giebułtowicz J. Development and application of a novel method for the determination of imatinib and N-desmethylimatinib in plasma based on molecularly imprinted sorbent in a solid-phase extraction process combined with liquid chromatography mass spectrometry detection. Microchemical Journal. 2025;217:1-13.
  27. Giebułtowicz J, Kucharski D, Nałęcz-Jawecki G, Skowronek A, Strzelecka A, Maciąg Ł, Drzewicz P. Factors Affecting Distribution of Pharmaceutically Active Compounds in Bottom Sediments of Odra River Estuary (SW Baltic Sea). Molecules. 2025;30(19):1-21.
  28. Witkowska A, Stolarczyk K, Fusaro M, Leś A, Giebułtowicz J, Stolarczyk E. Oxidation and Reduction of Hydrazones—Risk Factors Related to the Manufacture and Stability of the Drugs. International Journal of Molecular Sciences. 2025;26(9):1-20.
  29. Gątarek P, Pawełczyk M, Bobrowska-Korczak B, Giebułtowicz J, Głąbiński A, Kałużna-Czaplińska J. The Determination of Trimethylamine N-Oxide and Organic Acids Connected with Gut Microbiota in the Urine of Parkinson’s Disease Patients: A Pilot Study. International Journal of Molecular Sciences. 2025;26(10):1-20.
  30. Mazurek A, Franczak-Rogowska M, Szeleszczuk Ł. Isosymmetric Phase Transitions in Crystals: From Subtle Rearrangements to Functional Properties. Crystals. 2025;15(9):1-37.
  31. Nałęcz-Jawecki G, Wawryniuk M, Kopczyńska W, Giebułtowicz J. Individual and Simultaneous Photodegradation of Trimethoprim and Sulfamethoxazole Assessed with the Microbial Assay for Risk Assessment. Molecules. 2025;30(9):1-16.
  32. Sochacka M, Kózka B, Kurek E, Giebułtowicz J. Spirulina and Chlorella Dietary Supplements—Are They a Source Solely of Valuable Nutrients? International Journal of Molecular Sciences. 2025;26(21):1-25.
  33. Kocur A, Sobiak J, Czajkowska A, Rubik J, Pawiński T. Volumetric Absorptive Microsampling of Saliva for Pharmacokinetic Evaluation of Mycophenolic Acid and Its Glucuronide Metabolite in Pediatric Renal Transplant Recipients: Bioanalytical Method Validation and Clinical Feasibility Evaluation. Pharmaceuticals. 2025;18(11):1-21.
  34. Sobiech M, Luliński P, Synoradzki K, Bednarchuk T, Janczura M, Provorova V, Giebułtowicz J. Implementing magnetic molecularly imprinted solid phase extraction to analytical method for determination of 2-phenethylamine in cocoa powder and chocolate by LC-MS/MS system. Microchemical Journal. 2024;205:1-10.
  35. Thomas M, Nałęcz-Jawecki G, Giebułtowicz J, Drzewicz P. Degradation of oxytetracycline by ferrate(VI): Treatment optimization, UHPLC-MS/MS and toxicological studies of the degradation products, and impact of urea and creatinine on the removal. Chemical Engineering Journal. 2024;485:1-14.
  36. Dzyuba V, Giebułtowicz J, Dzyuba B, Fedorova G, Kholodnyy V, Kowalski R, Brzyszcz A, Boryshpolets S. Changes in sperm metabolome during carp sperm short-term storage in different media: In search of sperm quality and storage capability markers. Aquaculture. 2024;581:1-10.
  37. Giebułtowicz J, Ślusarczyk J, Wyderska S, Wroczyński P. The Impact of Organic Selenium (IV) on Hypericum perforatum L. under Cadmium Stress and Non-Stress Conditions. Plants. 2024;13(15):1-18.
  38. Stępień K, Kalicka A, Giebułtowicz J. Screening the quality of legal and illegal dietary supplements by LC-MS/MS. Food Additives & Contaminants Part B-Surveillance. 2024;17(4):328-341.
  39. Powała A, Żołek T, Brown G, Kutner A. Structure and the Anticancer Activity of Vitamin D Receptor Agonists. International Journal of Molecular Sciences. 2024;25(12):1-24.
  40. Michorowska S, Kucharski D, Chojnacka J, Nałęcz-Jawecki G, Marek D, Giebułtowicz J. Metabolomic study on ostracods exposed to environmentally relevant concentrations of five pharmaceuticals selected via a novel approach. Science of the Total Environment. 2024;946:1-12.
  41. Kot B, Moczulski M, Czajkowska A, Kocur A. Pharmacotherapy of apnea in the premature neonatological subpopulation – therapeutic opportunities, pharmacokinetic implications and recommendations for therapeutic drug monitoring. Prospects in Pharmaceutical Sciences. 2024;22(2):30-38.
  42. Kocur A, Kot B, Moczulski M, Czajkowska A, Rubik J, Sierakowski M, Pawiński T. A novel approach to therapeutic drug monitoring of Ciclosporin in pediatric renal transplant recipients using volumetric absorptive microsampling (VAMS) – Teaching old dog new tricks. Clinica Chimica Acta. 2024;562:1-11.
  43. Powała K, Żołek T, Brown G, Kutner A. Molecular Interactions of Selective Agonists and Antagonists with the Retinoic Acid Receptor γ. International Journal of Molecular Sciences. 2024;25(12):1-21.
  44. Wierzchowski K, Kawka M, Sykłowska-Baranek K, Pilarek M. Intensification of Rindera graeca transgenic roots proliferation and deoxyshikonin secretion in wave-agitated disposable bioreactor. Chemical Engineering and Processing-Process Intensification. 2024;203:1-8.
  45. Kocur A, Czajkowska A, Moczulski M, Kot B, Rubik J, Pawiński T. Assessment of Dried Serum Spots (DSS) and Volumetric-Absorptive Microsampling (VAMS) Techniques in Therapeutic Drug Monitoring of (Val)Ganciclovir—Comparative Study in Analytical and Clinical Practice. International Journal of Molecular Sciences. 2024;25(16):1-17.
  46. Kocur A, Mikulska A, Moczulski M, Pawiński T. Therapeutic Drug Monitoring of Low Methotrexate Doses for Drug Exposure and Adherence Assessment—Pre-Analytical Variables, Bioanalytical Issues, and Current Clinical Applications. International Journal of Molecular Sciences. 2024;25(24):1-19.
  47. Sochacka M, Hoser G, Remiszewska M, Suchocki P, Sikora K, Giebułtowicz J. Effect of Selol on Tumor Morphology and Biochemical Parameters Associated with Oxidative Stress in a Prostate Tumor-Bearing Mice Model. Nutrients. 2024;16(17):1-15.
  48. Drobniewska A, Giebułtowicz J, Wawryniuk M, Kierczak P, Nałęcz-Jawecki G. Toxicity and bioaccumulation of selected antidepressants in Lemna minor (L.). Ecohydrology & Hydrobiology. 2024;24(2):262-270.
  49. Michorowska S, Vogel K, Jain R, Clair S, Simcox J, Parks B. Liver-specific deletion of Agpat5 protects against liquid sucrose-induced hyperinsulinemia and glucose intolerance. Biochemical and Biophysical Research Communications. 2024;741:1-7.
  50. Wierzynska E, Nałęcz-Jawecki G, Giebułtowicz J, Drobniewska A, Łęcki T, Zarębska K, Skompska M. From aromatic rings to aliphatic compounds – Degradation of duloxetine with the use of visible light driven Z-scheme photocatalyst. Journal of Environmental Chemical Engineering. 2024;12(6):1-12.
  51. Kocur A, Czajkowska A, Rębis K, Rubik J, Moczulski M, Kot B, Sierakowski M, Pawiński T. Personalization of pharmacotherapy with sirolimus based on volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients—from LC-MS/MS method validation to clinical application. Pharmacological Reports. 2024;76(6):1443-1455.
  52. Stępień K, Myslitska D, Garbacz G, Paszkowska J, Giebułtowicz J. Pharmaceutical availability testing − can a drug-specific test be relevant for assessing the quality of dietary supplements? Microchemical Journal. 2024;207:1-12.
  53. Nowiński A, Chabowski D, Giebułtowicz J, Aleksandrowicz M, Ufnal M. Deoxycholic Acid, a Secondary Bile Acid, Increases Cardiac Output and Blood Pressure in Rats. Nutrients. 2024;16(1):1-13.
  54. Romański M, Giebułtowicz J, Gniazdowska E, (...), Danielak D. An extension of biorelevant fed-state dissolution tests to clinical pharmacokinetics – A study on gastrointestinal factors influencing rivaroxaban exposure and efficacy in atrial fibrillation patients. International Journal of Pharmaceutics. 2024;649:1-14.
  55. Nałęcz-Jawecki G, Giebułtowicz J, Chojnacka J, Pajchel Ł, Drobniewska A. The Sorption of Antidepressant Pharmaceuticals on Virgin and Aged Microplastics Is Lower than Bioconcentration in Protozoa. Water. 2024;16(17):1-14.
  56. Giebułtowicz J, Grabicová K, Brooks B, Grabic R. Influence of time-dependent sampling on the plasma metabolome and exposome of fish collected from an effluent-dependent pond. Science of the Total Environment. 2024;906:1-11.
  57. Michorowska S, Wiśniewska A, Wolinowska R, Wroczyński P, Giebułtowicz J. The Applicability and Limitations of the Spectrofluorometric Method for Determination of ALDH1 Activity in Serum and Plasma. Diagnostics. 2024;14(23):1-11.
  58. Urbaniak M, Baran A, Giebułtowicz J, Bednarek A, Serwecińska L. The occurrence of heavy metals and antimicrobials in sewage sludge and their predicted risk to soil — Is there anything to fear? Science of the Total Environment. 2024;912:1-14.
  59. Attanayake Mudiyanselage R, Mierzejewska-Sinner E, Giebułtowicz J, Kózka B, Tołoczko W, Bednarek A, Urbaniak M. Fertilizing drug resistance: Dissemination of antibiotic resistance genes in soil and plant bacteria under bovine and swine slurry fertilization. Science of the Total Environment. 2024;946:1-15.
  60. Figura M, Mrozowicz A, Milanowski Ł, Szlufik S, Raćkowska E, Lypkan H, Friedman A, Koziorowski D, Giebułtowicz J. Impact of Physical Exercise on Levodopa Therapy Across Parkinson’s Disease Stages. Journal of Parkinson’s Disease. 2024;14(5):1039-1049.
  61. Sobiech M, Khamanga S, Synoradzki K, Bednarchuk T, Sikora K, Luliński P, Giebułtowicz J. Molecularly Imprinted Drug Carrier for Lamotrigine—Design, Synthesis, and Characterization of Physicochemical Parameters. International Journal of Molecular Sciences. 2024;25(9):1-23.
  62. Rogulska J, Osowska S. Wskaźniki peroksydacji lipidów w żywieniu pozajelitowym. Prospects in Pharmaceutical Sciences. 2023;21(4):24-32.
  63. Kocur A, Rubik J, Czarnowski P, Czajkowska A, Marszałek D, Sierakowski M, Górska M, Pawiński T. Therapeutic drug monitoring of mycophenolic acid (MPA) using volumetric absorptive microsampling (VAMS) in pediatric renal transplant recipients: ultra-high-performance liquid chromatography-tandem mass spectrometry analytical method development, cross-validation, and clinical application. Pharmacological Reports. 2023;75(4):1026-1042.
  64. Balcer E, Sobiech M, Luliński P. Molecularly Imprinted Carriers for Diagnostics and Therapy—A Critical Appraisal. Pharmaceutics. 2023;15(6):1-19.
  65. Jastrzębska M, Giebułtowicz J, Ciechanowicz A, Wrzesień R, Bielecki W, Bobrowska-Korczak B. Effect of polyphenols and zinc co-supplementation on the development of neoplasms in rats with breast cancer. Foods. 2023;12(2):1-15.
  66. Kocur A, Kunicki P, Pawiński T. Generic Medicinal Products in Immunosuppressive Therapy—Should It be a Challenge for Therapeutic Drug Monitoring? Therapeutic Drug Monitoring. 2023;45(2):173-190.
  67. Gniazdowska E, Giebułtowicz J, Rudzki P. How does the order of sample analysis influence the matrix effect during LC-MS bioanalysis? Journal of Chromatography B. 2023;1227:1-11.
  68. Chojnacka J, Giebułtowicz J, Choińska N, Drobniewska A, Nałęcz-Jawecki G. Do Microplastics Affect the Photodegradation of Duloxetine and Its Phototoxicity to Protozoan Spirostomum ambiguum (Müller, 1786) Ehrenberg, 1835? Water. 2023;15(22):1-16.
  69. Yang T, Stogiannari M, Janeczko S, (...), Giebułtowicz J, (...), Alhnan M. Towards point-of-care manufacturing and analysis of immediate-release 3D printed hydrocortisone tablets for the treatment of congenital adrenal hyperplasia. International Journal of Pharmaceutics. 2023;642:1-9.
  70. Osredkar J, Žvar Baškoviˇc B, Finderle P, Bobrowska-Korczak B, (...), Giebułtowicz J, (...), Kałużna-Czaplińska J. Relationship between Excreted Uremic Toxins and Degree of Disorder of Children with ASD. International Journal of Molecular Sciences. 2023;24(8):1-14.
  71. Rogulska J, Osowska S, Zawada K, Giebułtowicz J. Effect of different amino acid solutions on the oxidative stability of three different lipid emulsions in all-in-one admixtures. Journal of Parenteral and Enteral Nutrition. 2023;47(5):646-653.
  72. Kocur A, Pawiński T. Volumetric Absorptive Microsampling in Therapeutic Drug Monitoring of Immunosuppressive Drugs—From Sampling and Analytical Issues to Clinical Application. International Journal of Molecular Sciences. 2023;24(1):1-28.
  73. Kózka B, Sośnicka A, Nałęcz-Jawecki G, Drobniewska A, Turło J, Giebułtowicz J. Various species of Basidiomycota fungi reveal different abilities to degrade pharmaceuticals and also different pathways of degradation. Chemosphere. 2023;338:1-12.
  74. Osredkar J, Kumer K, Fabjan T, (...), Bobrowska-Korczak B, (...), Giebułtowicz J, (...), Kałużna-Czaplińska J. Determination of modified nucleosides in the urine of children with autism spectrum disorder. Acta Biochimica Polonica. 2023;70(2):335-342.
  75. Yang T, Szewc J, Zhong L, Leonova A, Giebułtowicz J, Habashy R, Isreb A, Alhnan M. The Use of Near-infrared as Process Analytical Technology (PAT) during 3D Printing Tablets at the Point-of-Care. International Journal of Pharmaceutics. 2023;642:1-9.
  76. Witkowska A, Wołczyńska A, Lis-Cieplak A, Stolarczyk E. Development and Validation of LC-MS/MS Method for the Determination of 1-Methyl-4-Nitrosopiperazine (MNP) in Multicomponent Products with Rifampicin—Analytical Challenges and Degradation Studies. Molecules. 2023;28(21):1-15.
  77. Mikulska A, Kocur A. Pharmacotherapy with high doses of methotrexate (HDMTX) in oncology – how should chemotherapy be conducted based on therapeutic drug monitoring? Prospects in Pharmaceutical Sciences. 2023;21(4):40-47.
  78. Korytowska-Przybylska N, Michorowska S, Wyczałkowska-Tomasik A, Pączek L, Giebułtowicz J. Development of a novel method for the simultaneous detection of trimethylamine N-oxide and creatinine in the saliva of patients with chronic kidney disease - Its utility in saliva as an alternative to blood. Journal of Pharmaceutical and Biomedical Analysis. 2023;234:1-7.
  79. Kocur A, Marszałek D, Rubik J, Czajkowska A, Pawiński T. Therapeutic Drug Monitoring of Tacrolimus Based on Volumetric Absorptive Microsampling Technique (VAMS) in Renal Transplant Pediatric Recipients—LC-MS/MS Method Development, Hematocrit Effect Evaluation, and Clinical Application. Pharmaceutics. 2023;15(1):1-23.
  80. Sobiech M, Giebułtowicz J, Luliński P. Computational and experimental studies of magnetic molecularly imprinted sorbent with high specificity towards aceclofenac. Microchemical Journal. 2023;186:1-10.
  81. Sobiak J, Żero P, Zachwieja J, Ostalska-Nowicka D, Pawiński T. Limited sampling strategy to predict free mycophenolic acid area under the concentration–time curve in paediatric patients with nephrotic syndrome. Clinical and Experimental Pharmacology and Physiology. 2023;50(6):486-496.
  82. Kutner A. Recent advances in drug substance development – prodrug strategies for enhancing the bioavailability and potency of antiviral nucleosides. Journal of Medical Science. 2023;92(3):7-12.
  83. Balcer E, Sobiech M, Giebułtowicz J, Sochacka M, Luliński P. Molecularly Imprinted Polymers Specific towards 4-Borono-L-phenylalanine—Synthesis Optimization, Theoretical Analysis, Morphology Investigation, Cytotoxicity, and Release Studies. Polymers. 2023;15(14):1-19.
  84. Jain R, Geoghegan G, Davidson J, (...), Michorowska S, (...), Simcox J. Modulation of hepatic transcription factor EB activity during cold exposure uncovers direct regulation of bis(monoacylglycero)phosphate lipids by Pla2g15. bioRxiv : the preprint server for biology. 2023:1-40.
  85. Gniazdowska E, Gilant E, Buś-Kwaśnik K. Wytyczna ICH M10 - jednolite podejście do bioanalizy na całym świecie. Prospects in Pharmaceutical Sciences. 2023;21(3):57-63.
  86. Sobiech M, Klejn D, Kleniewski W, Luliński P, Giebułtowicz J. Imipramine-imprinted polymer: Designing by theoretical and empirical studies. Microchemical Journal. 2023;194:1-10.
  87. Lemaitre F, Budde K, Van Gelder T, (...), Pawiński T, (...), Langman L. Therapeutic Drug Monitoring and dosage adjustments of immunosuppressive drugs when combined with nirmatrelvir/ritonavir in patients with COVID-19. Therapeutic Drug Monitoring. 2023;45(2):191-199.
  88. Stec A, Maciejewska M, Paralusz-Stec K, Michalska M, Giebułtowicz J, Rudnicka L, Sikora M. The Gut Microbial Metabolite Trimethylamine N-Oxide is Linked to Specific Complications of Systemic Sclerosis. Journal of Inflammation Research. 2023;16:1895-1904.
  89. Stasiulewicz A, Leśniak A, Bujalska-Zadrożny M, Pawiński T, Sulkowska J. Identification of Novel CB2 Ligands through Virtual Screening and In Vitro Evaluation. Journal of Chemical Information and Modeling. 2023;63(3):1012-1027.
  90. Grodner B, Żołek T, Kutner A. Nonaqueous Capillary Electrophoretic Separation of Analogs of (24R)-1,24-Dihydroxyvitamin D3 Derivative as Predicted by Quantum Chemical Calculations. Molecules. 2023;28(13):1-12.
  91. Kutner A, Brown G, Kallay E. Novel Strategies in the Development of New Therapies, Drug Substances, and Drug Carriers Volume II. International Journal of Molecular Sciences. 2023;24(6):1-8.
  92. Stępień K, Krawczyk W, Giebułtowicz J. Dietary Supplements with Proline—A Comprehensive Assessment of Their Quality. Life. 2023;13(2):1-12.
  93. Kalicka A, Tarłowska N. Counterfeit and illegal medicinal products as an example of drugs that do not meet the basic quality requirements. Prospects in Pharmaceutical Sciences. 2023;21(4):10-23.
  94. Balcer E, Giebułtowicz J, Sochacka M, Ruszczyńska A, Muszyńska M, Bulska E. Investigation of the Impact of L-Phenylalanine and L-Tyrosine Pre-Treatment on the Uptake of 4-Borono-L-Phenylalanine in Cancerous and Normal Cells Using an Analytical Approach Based on SC-ICP-MS. Molecules. 2023;28(18):1-11.
  95. Lisowska-Myjak B, Zborowska H, Białek S, Wroczyński P, Kuch M, Skarżyńska E. Associations of Anthropometric Parameters with Thyroid Hormone Profiles and the Serum Proteins in Healthy Young Women in the Preconception Period. Epidemiology & Public Health. 2023;1(2):1-7.
  96. Kucharski D, Nałęcz-Jawecki G, Drzewicz P, Skowronek A, Mianowicz K, Strzelecka A, Giebułtowicz J. The assessment of environmental risk related to the occurrence of pharmaceuticals in bottom sediments of the Odra River estuary (SW Baltic Sea). Science of the Total Environment. 2022;828:1-10.
  97. Bodnar-Broniarczyk M, Warzyszyńska K, Czerwińska K, Marszałek D, Dziewa N, Kosieradzki M, Pawiński T. Development and Validation of the New Liquid Chromatography-Tandem Mass Spectrometry Method for the Determination of Unbound Tacrolimus in the Plasma Ultrafiltrate of Transplant Recipients. Pharmaceutics. 2022;14(3):1-13.
  98. Gleba J, Kłopotowska D, Banach J, Mielko K, Turlej E, Maciejewska M, Kutner A, Wietrzyk J. Micro-RNAs in Response to Active Forms of Vitamin D3 in Human Leukemia and Lymphoma Cells. International Journal of Molecular Sciences. 2022;23(9):1-22.
  99. Ozimiński W, Ramsden C. Valence tautomerism and recyclisation of type B mesoionic tetrazoles: a computational study. Structural Chemistry. 2022;33:229-235.
  100. Yadav J, Żołek T, Maciejewska D, Gilant E, Gniazdowska E, Kutner A, Noworyta K, Kutner W. Polytyramine film-coated single-walled carbon nanotube electrochemical chemosensor with molecularly imprinted polymer nanoparticles for duloxetine-selective determination in human plasma. ACS Sensors. 2022;7(7):1829-1836.
  101. Stępień K, Giebułtowicz J. Application of Liquid Chromatography Coupled to Mass Spectrometry in Quality Assessment of Dietary Supplements—A Case Study of Tryptophan Supplements: Release Assay, Targeted and Untargeted Studies. Pharmaceuticals. 2022;15(4):1-27.
  102. Berdyński M, Krawczyk P, Safranow K, Borzemska B, Szaflik J, Nowakowska-Żawrocka K, Żekanowski C, Giebułtowicz J. Common ALDH3A1 Gene Variant Associated with Keratoconus Risk in the Polish Population. Journal of Clinical Medicine. 2022;11(1):1-10.
  103. Żołek T, Yasuda K, Brown G, Sakaki T, Kutner A. In silico prediction of the metabolic resistance of vitamin D analogs against CYP3A4 metabolizing enzyme. International Journal of Molecular Sciences. 2022;23(14):1-14.
  104. Zielińska M, Hermanowski T. Sources of information on medicinal products among physicians – a survey conducted among primary care physicians in Poland. Frontiers in Pharmacology. 2022;12:1-10.
  105. Stolarczyk E, Groman A, Zezula M, Witkowska A. Application of GC-MS and LC-MS techniques for direct analysis of amines in pharmaceutical substances. Acta Poloniae Pharmaceutica - Drug Research. 2022;79(5):603-613.
  106. Kucharski D, Stasiuk R, Drzewicz P, Skowronek A, Strzelecka A, Mianowicz K, Giebułtowicz J. Fit-for-Purpose Assessment of QuEChERS LC-MS/MS Methods for Environmental Monitoring of Organotin Compounds in the Bottom Sediments of the Odra River Estuary. Molecules. 2022;27(15):1-12.
  107. Perlinska A, Stasiulewicz A, Nguyen M, Swiderska K, Zmudzinski M, Maksymiuk A, Drag M, Sulkowska J. Amino acid variants of SARS-CoV-2 papain-like protease have impact on drug binding. PLoS Computational Biology. 2022;18(11):1-22.
  108. Gleba J, Kłopotowska D, Banach J, (...), Kutner A, Wietrzyk J. Polymorphism of VDR Gene and the Sensitivity of Human Leukemia and Lymphoma Cells to Active Forms of Vitamin D. Cancers. 2022;14(2):1-19.
  109. Kucharski D, Giebułtowicz J, Drobniewska A, Nałęcz-Jawecki G, Skowronek A, Strzelecka A, Mianowicz K, Drzewicz P. The study on contamination of bottom sediments from the Odra River estuary (SW Baltic Sea) by tributyltin using environmetric methods. Chemosphere. 2022;308(Pt 1):1-10.
  110. Pinheiro W, Costa do Santos M, Farias G, (...), Suchocki P, (...), Rodrigues de Andrade L. Combination of selol nanocapsules and magnetic hyperthermia hinders breast tumor growth in aged mice after a short-time treatment. Nanotechnology. 2022;33(20):1-15.
  111. Sośnicka A, Kózka B, Makarova K, Giebułtowicz J, Klimaszewska M, Turło J. Optimization of White-Rot Fungi Mycelial Culture Components for Bioremediation of Pharmaceutical-Derived Pollutants. Water. 2022;14(9):1-27.
  112. Kutner A, Brown G, Kallay E. Novel Strategies in the Development of New Therapies, Drug Substances, and Drug Carriers Volume I. International Journal of Molecular Sciences. 2022;23(12):1-6.
  113. Wiśniowska B, Giebułtowicz J, Piotrowski R, Kułakowski P, Polak S. Development and Performance Verification of the PBPK Model for Antazoline and Its Metabolite and Its Utilization for Pharmacological Hypotheses Formulating. Pharmaceuticals. 2022;15(3):1-15.
  114. Piątek K, Kutner A, Castillo-Tong D, (...), Schepelmann M. Vitamin D Analogs Regulate the Vitamin D System and Cell Viability in Ovarian Cancer Cells. International Journal of Molecular Sciences. 2022;23(1):1-12.
  115. Lisowska-Myjak B, Zborowska H, Białek S, Wroczyński P, Kuch M, Skarżyńska E. Exploring associations of anthropometric parameters and serum triglycerides with serum thyroid hormones in young women. Scientific Reports. 2022;12:1-8.
  116. Stasiulewicz A, Leśniak A, Setny P, Bujalska-Zadrożny M, Sulkowska J. Identification of CB1 Ligands among Drugs, Phytochemicals and Natural-Like Compounds: Virtual Screening and In Vitro Verification. ACS Chemical Neuroscience. 2022;13(20):2991-3007.
  117. Koczoń P, Josefsson H, Michorowska S, (...), Gruczyńska-Sękowska E. The Influence of the Structure of Selected Polymers on Their Properties and Food-Related Applications. Polymers. 2022;14(10):1-28.
  118. J, Rybakiewicz-Sekita R, Żołek T, Maciejewska D, (...), Kutner A, (...), Kutner W. Cilostazol-imprinted polymer film-coated electrode as an electrochemical chemosensor for selective determination of cilostazol and its active primary metabolite. Journal of Materials Chemistry B. 2022;10(35):6707-6715.
  119. Sankowski B, Michorowska S, Raćkowska E, Sikora M, Giebułtowicz J. Saliva as Blood Alternative in Therapeutic Monitoring of Teriflunomide—Development and Validation of the Novel Analytical Method. International Journal of Molecular Sciences. 2022;23(17):1-12.
  120. Szlaska I, Pawiński T, Kukiełka M, Kośnik K. Validated HPLC-UV method for determination of venlafaxine and its metabolite – O-desmethylvenlafaxine in human plasma. Acta Poloniae Pharmaceutica - Drug Research. 2022;79(6):799-807.
  121. Wanat M, Malinska M, Kutner A, Woźniak K. First Experimental Quantitative Charge Density Studies of Advanced Intermediate of Vitamin D Analogues. Molecules. 2022;27(6):1-16.
  122. Poznanski P, Giebułtowicz J, Durdzinska J, Kocki T, Sacharczuk M, Bujalska-Zadrożny M, Leśniak A. Mechanisms Underlining Inflammatory Pain Sensitivity in Mice Selected for High and Low Stress-Induced Analgesia—The Role of Endocannabinoids and Microglia. International Journal of Molecular Sciences. 2022;23(19):1-17.
  123. Gniazdowska E, Goch W, Giebułtowicz J, Rudzki P. Replicates Number for Drug Stability Testing during Bioanalytical Method Validation—An Experimental and Retrospective Approach. Molecules. 2022;27(2):1-19.
  124. Sobiech M, Giebułtowicz J, Woźnica M, Jaworski I, Luliński P. Theoretical and experimental model of molecularly imprinted polymer surface microenvironment for selective stationary phase – Exemplary of S-pramipexole for potential pharmaceutical analysis. Microchemical Journal. 2022;182:1-12.
  125. Sobiech M, Synoradzki K, Bednarchuk T, Sobczak K, Janczura M, Giebułtowicz J, Luliński P. Impact of structure and magnetic parameters of nanocrystalline cores on surface properties of molecularly imprinted nanoconjugates for analysis of biomolecules – A case of tyramine. Microchemical Journal. 2022;179:1-10.
  126. Witkowska A, Giebułtowicz J, Dąbrowska M, Stolarczyk E. Development of a Sensitive Screening Method for Simultaneous Determination of Nine Genotoxic Nitrosamines in Active Pharmaceutical Ingredients by GC-MS. International Journal of Molecular Sciences. 2022;23(20):1-11.
  127. Bobrowska-Korczak B, Stawarska A, Szterk A, Ofiara K, Czerwonka M, Giebułtowicz J. Determination of Pharmaceuticals, Heavy Metals, and Oxysterols in Fish Muscle. Molecules. 2021;26(5):1-16.
  128. Janczura M, Sobiech M, Giebułtowicz J, Luliński P. Computational and experimental designing of imprinted sorbent for the determination of nitroxidative stress products: an analysis of 4-hydroxyphenylacetic acid conversion. Journal of Materials Science. 2021;56(14):8439-8460.
  129. Giebułtowicz J, Korytowska N, Sobiech M, Polak S, Wiśniowska B, Piotrowski R, Kułakowski P, Luliński P. Magnetic Core–Shell Molecularly Imprinted Nano-Conjugates for Extraction of Antazoline and Hydroxyantazoline from Human Plasma—Material Characterization, Theoretical Analysis and Pharmacokinetics. International Journal of Molecular Sciences. 2021;22(7):1-19.
  130. Rogulska J, Osowska S, Kunecki M, Sobocki J, Ładażyński P, Giebułtowicz J. Antioxidant balance in plasma of patients on home parenteral nutrition: A pilot study comparing three different lipid emulsions. Clinical Nutrition. 2021;40(6):3950-3958.
  131. Sikora M, Kiss N, Stec A, Giebułtowicz J, Samborowska E, (...), Olszewska M, Rudnicka L. Trimethylamine N-Oxide, a Gut Microbiota-Derived Metabolite, Is Associated with Cardiovascular Risk in Psoriasis: A Cross-Sectional Pilot Study. Dermatology and Therapy. 2021;11(4):1277-1289.
  132. Pieńko T, Czarnecki J, Równicki M, Wojciechowska M, Wierzba A, Gryko D, Bartosik D, Trylska J. Vitamin B 12-peptide nucleic acids use the BtuB receptor to pass through the Escherichia coli outer membrane. Biophysical Journal. 2021;120(4):725-737.
  133. Kunicki P, Wróbel A. Validated Simple HPLC-UV Method for Mycophenolic Acid (MPA) Monitoring in Human Plasma. Internal Standardization: Is It Necessary? Molecules. 2021;26(23):1-17.
  134. Hubeny J, Harnisz M, Korzeniewska E, (...), Giebułtowicz J, Nałęcz-Jawecki G, Płaza G. Industrialization as a source of heavy metals and antibiotics which can enhance the antibiotic resistance in wastewater, sewage sludge and river water. PLoS One. 2021;16(6):1-24.
  135. Sikora M, Stec A, Chrabaszcz M, Giebułtowicz J, (...), Olszewska M, Rudnicka L. Clinical Implications of Intestinal Barrier Damage in Psoriasis. Journal of Inflammation Research. 2021;14:237-243.
  136. Luliński P, Janczura M, Sobiech M, Giebułtowicz J. Magnetic Molecularly Imprinted Nano-Conjugates for Effective Extraction of Food Components—A Model Study of Tyramine Determination in Craft Beers. International Journal of Molecular Sciences. 2021;22(17):1-18.
  137. Gniazdowska E, Kaza M, Buś-Kwaśnik K, Giebułtowicz J. LC-MS/MS determination of dutasteride and its major metabolites in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 2021;206:1-9.
  138. Ozimiński W, Wiśniewski I. Quantum-chemical study on the relative stability of sildenafil tautomers. Structural Chemistry. 2021;32(5):1733-1743.
  139. Michorowska S. Ataluren - Promising Therapeutic Premature Termination Codon Readthrough Frontrunner. Pharmaceuticals. 2021;14(8):1-36.
  140. Bousquet J, Anto J, Czarlewski W, (...), Zuberbier T, Group A [grupa robocza], Białoszewski A [uczestnik grupy roboczej], Samoliński B [uczestnik grupy roboczej], Wroczyński P [uczestnik grupy roboczej], Raciborski F [uczestnik grupy roboczej], Białek S [uczestnik grupy roboczej]. Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19. Allergy. 2021;76(3):735-750.
  141. Winiecka I, Marszałek D, Jaworski P, Mazurek A, Pęcak P, Winiecki K, Wierzbowski A. Synthesis and docking studies of renin inhibitors containing ester and amide derivatives of (3s, 4s)-4-amino-hydroxy acids with s3-s3’ renin binding site. Acta Poloniae Pharmaceutica - Drug Research. 2021;78(1):55-70.
  142. Filip-Psurska B, Psurski M, Anisiewicz A, (...), Kutner A, Wietrzyk J. Vitamin D Compounds PRI-2191 and PRI-2205 Enhance Anastrozole Activity in Human Breast Cancer Models. International Journal of Molecular Sciences. 2021;22(5):1-24.
  143. Korytowska N, Wyczałkowska-Tomasik A, Pączek L, Giebułtowicz J. Evaluation of Salivary Indoxyl Sulfate with Proteinuria for Predicting Graft Deterioration in Kidney Transplant Recipients. Toxins. 2021;13(8):1-13.
  144. Bodnar-Broniarczyk M, Durlik M, Bączkowska T, Czerwińska K, Marszałek R, Pawiński T. Kidney and liver tissue tacrolimus concentrations in adult transplant recipients - the influence of the whole blood and tissue concentrations on efficiency of treatment during immunosuppressive therapy. Pharmaceutics. 2021;13(10):1-14.
  145. Bergan S, Brunet M, Hesselink D, (...), Kunicki P, (...), Pawiński T, (...), Langman L. Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Therapeutic Drug Monitoring. 2021;43(2):150-200.
  146. Banys K, Giebułtowicz J, Sobczak M, Wyrębiak R, Bielecki W, Wrzesień R, Bobrowska-Korczak B. Effect of Genistein Supplementation on the Progression of Neoplasms and the Level of the Modified Nucleosides in Rats With Mammary Cancer. In Vivo. 2021;35(4):2059-2072.
  147. Kózka B, Bębas K. Pozostałości substancji farmakologicznie czynnych jako zanieczyszczenie środowiska i rola grzybów białej zgnilizny w ich usuwaniu. Biuletyn Wydziału Farmaceutycznego Warszawskiego Uniwersytetu Medycznego. 2021;19(5):42-63.
  148. Ramsden C, Ozimiński W. The influence of exocyclic lone pairs on the bonding and geometry of type A mesoionic rings. Structural Chemistry. 2021;32(5):2075-2081.
  149. Bousquet J, Anto J, Bachert C, (...), Samoliński B, (...), Bialek S, (...), Pinnock H, (...), Raciborski F, (...), Wroczyński P, (...), Zidarn M. ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice. Allergy. 2021;76(1):168-190.
  150. Stasiulewicz A, Maksymiuk A, Nguyen M, Bełza B, Sulkowska J. SARS-CoV-2 Papain-Like Protease Potential Inhibitors-In Silico Quantitative Assessment. International Journal of Molecular Sciences. 2021;22(8):1-30.
  151. Yadav J, Gonzato C, Żołek T, Maciejewska D, Kutner A, (...), Kutner W. Molecularly imprinted polymer nanoparticles-based electrochemical chemosensors for selective determination of cilostazol and its pharmacologically active primary metabolite in human plasma. Biosensors & Bioelectronics. 2021;193:1-9.
  152. Bobrowska-Korczak B, Domanska K, Skrajnowska D, Wrzesień R, Giebułtowicz J, (...), Wyrębiak R, Piotrowska U, Sobczak M, Kałużna-Czaplińska J. Nanosized zinc, epigenetic changes and its relationship with DMBA induced breast cancer in rats. Reviews in Analytical Chemistry. 2020;39(1):200-208.
  153. Nowakowska K, Giebułtowicz J, Kamaszewski M, (...), Solarska-Dzięciołowska U, Nałęcz-Jawecki G, Wroczyński P, Drobniewska A. Acute exposure of zebrafish (Danio rerio) larvae to environmental concentrations of selected antidepressants: Bioaccumulation, physiological and histological changes. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology. 2020;229:1-9.
  154. Perlinska A, Stasiulewicz A, Nawrocka E, Kazimierczuk K, Setny P, Sulkowska J. Restriction of S-adenosylmethionine conformational freedom by knotted protein binding sites. PLoS Computational Biology. 2020;16(5):1-25.
  155. Giebułtowicz J, Korytowska N, Piotrowski R, Kułakowski P, Latacz G, Szymańska E, Wiśniowska B, Polak S. Characterization of In Vitro and In Vivo Metabolism of Antazoline Using Liquid Chromatography-Tandem Mass Spectrometry. International Journal of Molecular Sciences. 2020;21(24):1-18.
  156. Ozimiński W, Wójtowicz A. New theoretical insights on tautomerism of hyperforin - a prenylated phloroglucinol derivative which may be responsible for St. John’s wort (Hypericum perforatum) antidepressant activity. Structural Chemistry. 2020;31:657-666.
  157. Błażewicz A, Szymańska I, Dolliver W, Suchocki P, Turło J, Skórzyńska-Dziduszko K. Are Obese Patients with Autism Spectrum Disorder More Likely to Be Selenium Deficient? Research Findings on Pre- and Post-Pubertal Children. Nutrients. 2020;12(11):1-16.
  158. Wanat M, Malińska M, Kutner A, Woźniak K. Relation between crystal structures of precursors and final products: example of vitamin D intermediates. Molecules. 2020;25(8):1-15.
  159. Nałęcz-Jawecki G, Wawryniuk M, Giebułtowicz J, Olkowski A, Drobniewska A. Influence of Selected Antidepressants on the Ciliated Protozoan Spirostomum ambiguum: Toxicity, Bioaccumulation, and Biotransformation Products. Molecules. 2020;25(7):1-18.
  160. Gajda M, Rybakiewicz R, Cieplak M, Żołek T, Maciejewska D, (...), Kutner A, (...), Noworyta K. Low-oxidation-potential thiophene-carbazole monomers for electro-oxidative molecular imprinting: Selective chemosensing of aripiprazole. Biosensors & Bioelectronics. 2020;169:1-10.
  161. Korytowska N, Pytlak B, Niemczyk M. Przewlekła choroba nerek oraz wybrane aspekty monitorowania stanu biorców nerki. Biuletyn Wydziału Farmaceutycznego Warszawskiego Uniwersytetu Medycznego. 2020;(4):27-39.
  162. Kunicki P. Rola diagnosty laboratoryjnego w terapii monitorowanej stężeniem leku. Diagnosta Laboratoryjny. 2020;18(4):20-23.
  163. Sankowski B, Księżarczyk K, Raćkowska E, Szlufik S, Koziorowski D, Giebułtowicz J. Higher cerebrospinal fluid to plasma ratio of p-cresol sulfate and indoxyl sulfate in patients with Parkinson’s disease. Clinica Chimica Acta. 2020;501:165-173.
  164. Stasiulewicz A, Znajdek K, Grudzień M, Pawiński T, Sułkowska J. A Guide to Targeting the Endocannabinoid System in Drug Design. International Journal of Molecular Sciences. 2020;21(8):1-45.
  165. Mosiniewicz-Szablewska E, Tedesco A, Suchocki P, Morais P. Magnetic studies of polylactic- co-glicolic acid nanocapsules loaded with selol and γ-Fe 2 O 3 nanoparticles. Physical Chemistry Chemical Physics. 2020;22(37):21042-21058.
  166. Baliś B, Byrski A, Dekster L, (...), Giebułtowicz J, (...), Polak S. Drug Therapy Optimization System Based on a Hybrid Approach Combining Clinical Data and In Silico Modeling - Perspective View and Concept Description. International Review on Modelling and Simulations. 2020;13(4):234-242.
  167. Giebułtowicz J, Nałęcz-Jawecki G, Harnisz M, Kucharski D, Korzeniewska E, Płaza G. Environmental Risk and Risk of Resistance Selection Due to Antimicrobials' Occurrence in Two Polish Wastewater Treatment Plants and Receiving Surface Water. Molecules. 2020;25(6):1-22.
  168. Pieńko T, Trylska J. Extracellular loops of BtuB facilitate transport of vitamin B12 through the outer membrane of E. coli. PLoS Computational Biology. 2020;16(7):1-25.
  169. Muszyńska B, Kała K, Włodarczyk A, Krakowska A, Ostachowicz B, Gdula-Argasińska J, Suchocki P. Lentinula edodes as a Source of Bioelements Released into Artificial Digestive Juices and Potential Anti-inflammatory Material. Biological Trace Element Research. 2020;194(2):603-613.
  170. Zyguła A, Kosiński P, Wroczyński P, Makarewicz-Wujec M, Pietrzak B, Wielgoś M, Giebułtowicz J. Oxidative Stress Markers Differ in Two Placental Dysfunction Pathologies: Pregnancy-Induced Hypertension and Intrauterine Growth Restriction. Oxidative Medicine and Cellular Longevity. 2020;2020:1-12.
  171. Kucharski D, Drzewicz P, Nałęcz-Jawecki G, Mianowicz K, Skowronek A, Giebułtowicz J. Development and Application of a Novel QuEChERS Method for Monitoring of Tributyltin and Triphenyltin in Bottom Sediments of the Odra River Estuary, North Westernmost Part of Poland. Molecules. 2020;25(3):1-22.
  172. Kózka B, Nałęcz-Jawecki G, Turło J, Giebułtowicz J. Application of Pleurotus ostreatus to efficient removal of selected antidepressants and immunosuppressant. Journal of Environmental Management. 2020;273:1-8.
  173. Brown G, Kutner A, Marcinkowska E. Vitamin D and haematopoiesis. Current Tisue Microenvironment Reports . 2020;1:1-11.
  174. Milczarek M, Chodyński M, Pietraszek A, Stachowicz-Suhn M, Yasuda K, Sakaki T, Wietrzyk J, Kutner A. Synthesis, CYP24A1-Dependent Metabolism and Antiproliferative Potential against Colorectal Cancer Cells of 1,25-Dihydroxyvitamin D 2 Derivatives Modified at the Side Chain and the A-Ring. International Journal of Molecular Sciences. 2020;21(2):1-12.
  175. Balcer E, Mazur M. Nanocząstki złota w diagnostyce i terapii nowotworów – wybrane zastosowania. Biuletyn Wydziału Farmaceutycznego Warszawskiego Uniwersytetu Medycznego. 2020;(1):1-9.
  176. Piotrowska A, Wierzbicka J, Kwiatkowska K, Chodyński M, Kutner A, Żmijewski M. Antiproliferative activity of side-chain truncated vitamin D analogs (PRI-1203 and PRI-1204) against human malignant melanoma cell lines. European Journal of Pharmacology. 2020;881:1-12.
  177. Gniazdowska E, Korytowska N, Kłudka G, Giebułtowicz J. Determination of Antidepressants in Human Plasma by Modified Cloud-Point Extraction Coupled with Mass Spectrometry. Pharmaceuticals. 2020;13(12):1-25.
  178. Bobrowska-Korczak B, Skrajnowska D, Giebułtowicz J, Kiss A. The effect of selenium, zinc and copper on the excretion of urinary modified nucleobases in rats treated with prostate cancer cells. Reviews in Analytical Chemistry. 2020;39(1):106-115.
  179. Sobiech M, Giebułtowicz J, Luliński P. Application of Magnetic Core-Shell Imprinted Nanoconjugates for the Analysis of Hordenine in Human Plasma-Preliminary Data on Pharmacokinetic Study after Oral Administration. Journal of Agricultural and Food Chemistry. 2020;68(49):14502-14512.
  180. Sobiech M, Giebułtowicz J, Luliński P. Theoretical and experimental proof for selective response of imprinted sorbent – analysis of hordenine in human urine. Journal of Chromatography A. 2020;1613:1-13.
  181. Bédard A, Antó J, Fonseca J, (...), Samoliński B, (...), Basagaña X, The MASK Study Group [grupa robocza], Szylling A [uczestnik grupy roboczej], Lipiec A [uczestnik grupy roboczej], Białoszewski A [uczestnik grupy roboczej], Krzych-Fałta E [uczestnik grupy roboczej], Raciborski F [uczestnik grupy roboczej], Strozek J [uczestnik grupy roboczej], Białek S [uczestnik grupy roboczej], Wroczyński P [uczestnik grupy roboczej]. Correlation between work impairment, scores of rhinitis severity and asthma using the MASK-air ® App. Allergy. 2020;75(7):1672-1688.
  182. Kocur A, Marszałek D, Pawiński T. Zastosowanie metod analitycznych w oznaczaniu aktywności dehydrogenazy inozynomonofosforanowej (IMPDH) podczas terapii immunosupresyjnej. Biuletyn Wydziału Farmaceutycznego Warszawskiego Uniwersytetu Medycznego. 2020;(5):40-49.
  183. Muszyńska B, Szacawa E, Boderska-Łojewska D, (...), Suchocki P, (...), Pieszka M. Preliminary study on Se-enriched Lentinula edodes mycelium as a proposal of new feed additive in selenium deficiency. PLoS One. 2020;15(5):1-19.
  184. Gątarek P, Kałużna-Czaplińska J, Pawełczyk M, Jastrzębski K, Giebułtowicz J, Głąbiński A, Bobrowska-Korczak B. LC-MS/MS Determination of Modified Nucleosides in The Urine of Parkinson’s Disease and Parkinsonian Syndromes Patients. Molecules. 2020;25(21):1-15.
  185. Kojro G, Wroczyński P. Cloud Point Extraction in the Determination of Drugs in Biological Matrices. Journal of Chromatographic Science. 2020;58(2):151-162.
  186. Chodkowska A, Bieńkowska-Tokarczyk A, Słyk Ż, Giebułtowicz J, Małecki M. Anticancer activity of topical ointments with histone deacetylase inhibitor, trichostatin A. Advances in Clinical and Experimental Medicine. 2020;29(9):1039-1049.
  187. Bousquet J, Schünemann H, Togias A, (...), Samoliński B, (...), Białek S, (...), Raciborski F, (...), Wroczyński P, (...), Zidarn M, ARIA Study Group [grupa robocza], MASK Study Group [grupa robocza], Szylling A [uczestnik grupy roboczej], Lipiec A [uczestnik grupy roboczej], Strozek J [uczestnik grupy roboczej], Białoszewski A [uczestnik grupy roboczej], Krzych-Fałta E [uczestnik grupy roboczej]. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases. Clinical and Translational Allergy. 2019;9:1-15.
  188. Bodnar-Broniarczyk M, Pawiński T, Kunicki P. Isotope–labeled versus analog internal standard in LC–MS/MS method for tacrolimus determination in human whole blood samples – A compensation of matrix effects. Journal of Chromatography B. 2019;1104:220-227.
  189. Brunet M, van Gelder T, Asberg A, (...), Kunicki P, (...), Pawiński T, (...), Bergan S. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report. Therapeutic Drug Monitoring. 2019;41(3):261-307.
  190. Michorowska S, Giebułtowicz J, Wolinowska R, Konopka A, Wilkaniec A, Krajewski P, Bulska E, Wroczyński P. Detection of ALDH3B2 in Human Placenta. International Journal of Molecular Sciences. 2019;20(24):1-19.
  191. Kojro G, Rudzki P, Pisklak D, Giebułtowicz J. Matrix effect screening for cloud-point extraction combined with liquid chromatography coupled to mass spectrometry: Bioanalysis of pharmaceuticals. Journal of Chromatography A. 2019;1591:44-54.
  192. Rycerz K, Stępień K, Czapiewska M, Arafat B, Habashy R, Isreb A, Peak M, Alhnan M. Embedded 3D Printing of Novel Bespoke Soft Dosage Form Concept for Pediatrics. Pharmaceutics. 2019;11(12):1-15.
  193. Łuszczyńska P, Pawiński T, Kunicki P. Prediction of free mycophenolic acid concentrations and free fraction in adult lupus nephritis patients. Therapeutic Drug Monitoring. 2019;41(3):406-408.
  194. Smolkin B, Khononov A, Pieńko T, Shavit M, Belakhov V, Trylska J, Baasov T. Towards Catalytic Antibiotics: Redesign of Aminoglycosides To Catalytically Disable Bacterial Ribosomes. ChemBioChem. 2019;20(2):247-259.
  195. Sobiak J, Resztak M, Pawiński T, Żero P, Ostalska-Nowicka D, Zachwieja J, Chrzanowska M. Limited sampling strategy to predict mycophenolic acid area under the curve in pediatric patients with nephrotic syndrome: a retrospective cohort study. European Journal of Clinical Pharmacology. 2019;75(9):1249-1259.
  196. Menditto E, Costa E, Midao L, (...), Białek S, (...), Samoliński B, (...), Bousquet J, The MASK Study Group [grupa robocza], Szylling A [uczestnik grupy roboczej], Lipiec A [uczestnik grupy roboczej], Białoszewski A [uczestnik grupy roboczej], Krzych-Fałta E [uczestnik grupy roboczej], Raciborski F [uczestnik grupy roboczej], Strozek J [uczestnik grupy roboczej], Wroczyński P [uczestnik grupy roboczej]. Adherence to treatment in allergic rhinitis using mobile technology. The mask study. Clinical and Experimental Allergy. 2019;49(4):442-460.
  197. Berkowska K, Corcoran A, Grudzień M, Jakuszak A, Chodyński M, Kutner A, Marcinkowska E. Investigating the Role of VDR and Megalin in Semi-Selectivity of Side-Chain Modified 19- nor Analogs of Vitamin D. International Journal of Molecular Sciences. 2019;20(17):1-14.
  198. Korytowska N, Wyczałkowska-Tomasik A, Wiśniewska A, Pączek L, Giebułtowicz J. Development of the LC-MS/MS method for determining the p-cresol level in plasma. Journal of Pharmaceutical and Biomedical Analysis. 2019;167:149-154.
  199. Bobrowska-Korczak B, Gątarek P, Rosiak A, Giebułtowicz J, Kałużna-Czaplińska J. Reduced levels of modified nucleosides in the urine of autistic children. Preliminary studies. Analytical Biochemistry. 2019;571:62-67.
  200. Wołyniec W, Kasprowicz K, Giebułtowicz J, Korytowska N, (...), Ratkowski W. Changes in Water Soluble Uremic Toxins and Urinary Acute Kidney Injury Biomarkers After 10- and 100-km Runs. International Journal of Environmental Research and Public Health. 2019;16(21):1-19.
  201. Grosicka-Maciąg E, Kurpios-Piec D, Woźniak K, Kowalewski C, Szumiło M, (...), Suchocki P, Rahden-Staroń I. Selol (Se IV) modulates adhesive molecules in control and TNF-α-stimulated HMEC-1 cells. Journal of Trace Elements in Medicine and Biology. 2019;51:106-114.
  202. Zyguła A, Kosiński P, Zwierzchowska A, Sochacka M, Wroczyński P, Makarewicz-Wujec M, Pietrzak B, Wielgoś M, (...), Giebułtowicz J. Oxidative stress markers in saliva and plasma differ between diet-controlled and insulin-controlled gestational diabetes mellitus. Diabetes Research and Clinical Practice. 2019;148:72-80.
  203. Korytowska N, Sankowski B, Wyczałkowska-Tomasik A, Pączek L, Wroczyński P, Giebułtowicz J. The utility of saliva testing in the estimation of uremic toxin levels in serum. Clinical Chemistry and Laboratory Medicine. 2019;57(2):230-237.
  204. Łuszczyńska P, Pawiński T, Kunicki P, Durlik M, Augustyniak-Bartosik H, Hurkacz M. Pharmacokinetics of free and total mycophenolic acid in adult lupus nephritis patients-implications for therapeutic drug monitoring. European Journal of Clinical Pharmacology. 2019;75(3):371-379.
  205. Giebułtowicz J, Sobiech M, Rużycka M, Luliński P. Theoretical and experimental approach to hydrophilic interaction dispersive solid-phase extraction of 2-aminothiazoline-4-carboxylic acid from human post-mortem blood. Journal of Chromatography A. 2019;1587:61-72.
  206. Drzewicz P, Drobniewska A, Sikorska K, Nałęcz-Jawecki G. Analytical and ecotoxicological studies on degradation of fluoxetine and fluvoxamine by potassium ferrate. Environmental Technology. 2019;40(25):3265-3275.
  207. Milczarek M, Rossowska J, Klopotowska D, Stachowicz M, Kutner A, Wietrzyk J. Tacalcitol increases the sensitivity of colorectal cancer cells to 5-fluorouracil by downregulating the thymidylate synthase. Journal of Steroid Biochemistry and Molecular Biology. 2019;190:139-151.
  208. Sonet J, Mosca M, Bierla K, (...), Suchocki P, (...), Chavatte L. Selenized Plant Oil Is an Efficient Source of Selenium for Selenoprotein Biosynthesis in Human Cell Lines. Nutrients. 2019;11(7):1-13.
  209. Stępień K, Niewiarowski J, Harasimiuk A. Powszechność suplementów diety a zagrożenia związane z ich stosowaniem. Biuletyn Wydziału Farmaceutycznego Warszawskiego Uniwersytetu Medycznego. 2019;(9):51-59.
  210. Jabłońska A, Stępień K. Fałszowanie produktów leczniczych oraz zagrożenia wynikające z ich stosowania. Biuletyn Wydziału Farmaceutycznego Warszawskiego Uniwersytetu Medycznego. 2019;(11):66-71.
  211. Bosnic-Anticevich S, Costa E, Menditto E, (...), Białek S, (...), Wroczyński P, (...), Samoliński B, (...), Bousquet J. ARIA pharmacy 2018 "Allergic rhinitis care pathways for community pharmacy". Allergy. 2019;74(7):1219-1236.
  212. Arlouskaya Y, Sawicka A, Głowala M, Giebułtowicz J, Korytowska N, Tałałaj M, Nowicka G, Wrzosek M. Asymmetric Dimethylarginine (ADMA) and Symmetric Dimethylarginine (SDMA) Concentrations in Patients with Obesity and the Risk of Obstructive Sleep Apnea (OSA). Journal of Clinical Medicine. 2019;8(6):1-15.
  213. Woinska M, Wanat M, Taciak P, Pawiński T, Minor W, Wozniak K. Energetics of interactions in the solid state of 2-hydroxy-8-X-quinoline derivatives (X = Cl, Br, I, S-Ph): comparison of hirshfeld atom, X-ray wavefunction and multipole refinements. International Union of Crystallography Journal (IUCrJ). 2019;6(5):868-883.
  214. Isreb A, Baj K, Wojsz M, Isreb M, Peak M, Alhnan M. 3D printed oral theophylline doses with innovative 'radiator-like' design: Impact of polyethylene oxide (PEO) molecular weight. International Journal of Pharmaceutics. 2019;564:98-105.
  215. Maj E, Trynda J, Maj B, Gębura K, Bogunia-Kubik K, Chodyński M, Kutner A, Wietrzyk J. Differential response of lung cancer cell lines to vitamin D derivatives depending on EGFR, KRAS, p53 mutation status and VDR polymorphism. Journal of Steroid Biochemistry and Molecular Biology. 2019;193:1-10.
  216. Zgadzaj A, Giebułtowicz J, Gubernator J, Podbielska M, Sommer S, Zaremba-Czogalla M, Nałęcz-Jawecki G. Multi- and unilamellar liposomal encapsulation of ciprofloxacin as ways to modify its phototoxicity and photodegradation. European Journal of Pharmaceutical Sciences. 2019;129:181-189.
  217. Bousquet J, Hellings P, Agache I, (...), Samoliński B, (...), Zuberbier T, MASK Study Group [grupa robocza], Krzych-Fałta E [uczestnik grupy roboczej], Raciborski F [uczestnik grupy roboczej], Wroczyński P [uczestnik grupy roboczej], Białek S [uczestnik grupy roboczej]. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology. Journal of Allergy and Clinical Immunology. 2019;143(3):864-879.
  218. Piekoszewska-Ziętek P, Raćkowska E, Korytowska N, Olczak-Kowalczyk D. Salivary antioxidant status and oral health in children and adolescents. New Medicine. 2019;23(4):145-151.
  219. Pieńko T, Trylska J. Computational Methods Used to Explore Transport Events in Biological Systems. Journal of Chemical Information and Modeling. 2019;59(5):1772-1781.
  220. Raćkowska E, Bobrowska-Korczak B, Giebułtowicz J. Development and validation of a rapid LC–MS/MS method for determination of methylated nucleosides and nucleobases in urine. Journal of Chromatography B. 2019;1128:1-8.
  221. Kubica K, Taciak P, Czajkowska A, Sztokfisz-Ignasiak A, Wyrębiak R, Młynarczuk-Biały I, Malejczyk J, Mazurek A. Synthesis and anticancer activity evaluation of novel derivatives of 7-amino-4-methylquinolin-2(1h)-one. Acta Poloniae Pharmaceutica - Drug Research. 2018;75(4):903-910.
  222. Wawryniuk M, Drobniewska A, Sikorska K, Nałęcz-Jawecki G. Influence of photolabile pharmaceuticals on the photodegradation and toxicity of fluoxetine and fluvoxamine. Environmental Science and Pollution Research. 2018;25(7):6890-6898.
  223. Marszałek R, Paradowska K, Wawer I. Bioaktywne związki grzybów z rodzaju Lactarius. Herbalism. 2018;4(1):65-73.
  224. Kublin E, Malanowicz E, Zajączkowska A, Czerwińska K, Wyszomirska E, Mazurek A. Development of methods for determining excipients in cholesterol lowering drugs. Acta Poloniae Pharmaceutica - Drug Research. 2018;75(3):591-602.
  225. Taciak P, Łysenko N, Mazurek A. Drugs which influence serotonin transporter and serotonergic receptors: Pharmacological and clinical properties in the treatment of depression. Pharmacological Reports. 2018;70(1):37-46.
  226. Popławska M, Błażewicz A, Kamiński K, Bednarek E, Fijałek Z, Kozerski L. Application of high-performance liquid chromatography with charged aerosol detection (LC-CAD) for unified quantification of synthetic cannabinoids in herbal blends and comparison with quantitative NMR results. Forensic Toxicology. 2018;36(1):122-140.
  227. Sabbavarapu N, Pieńko T, Zalman B, Trylska J, Baasov T. Exploring eukaryotic versus prokaryotic ribosomal RNA recognition with aminoglycoside derivatives. MedChemComm. 2018;9(3):503-508.
  228. Ganassin R, Souza L, Rapp Py-Daniel K, (...), Suchocki P, (...), Muehlmann L. Decoration of a Poly(methyl vinyl ether-co-maleic anhydride)-Shelled Selol Nanocapsule with Folic Acid Increases Its Activity Against Different Cancer Cell Lines In Vitro. Journal of Nanoscience and Nanotechnology. 2018;18(1):522-528.
  229. Mielczarek L, Chilmonczyk Z, Suchocki P, Wroczyński P, Wiktorska K. Combinations of isothiocyanates with drugs - a chance or threat to chemoprevention and cancer treatment? Acta Poloniae Pharmaceutica - Drug Research. 2018;75(4):829-841.
  230. Ozimiński W, Ramsden C. The influence of substituent field and resonance effects on the ease of N-heterocyclic carbene formation from imidazolium rings. RSC Advances. 2018;8(27):14833-14837.
  231. Sochacka M, Giebułtowicz J, Remiszewska M, Suchocki P, Wroczyński P. Effects of Selol 5% supplementation on tissue antioxidant enzyme levels and peroxidation marker in healthy mice. Pharmacological Reports. 2018;70(6):1073-1078.
  232. Piątek T, Giebułtowicz J, Rüth M, (...), Wroczyński P, Hreńczuk M, Małkowski P, Rózga J. Albumin Apheresis for Artificial Liver Support: In Vitro Testing of a Novel Filter. Therapeutic Apheresis and Dialysis. 2018;22(4):399-409.
  233. Równicki M, Pieńko T, Czarnecki J, Kolanowska M, Bartosik D, Trylska J. Artificial Activation of Escherichia coli mazEF and hipBA Toxin-Antitoxin Systems by Antisense Peptide Nucleic Acids as an Antibacterial Strategy. Frontiers in Microbiology. 2018;9:1-12.
  234. Kubica K, Taciak P, Czajkowska A, Sztokfisz-Ignasiak A, Wyrębiak R, Podsadni P, Młynarczuk-Biały I, Malejczyk J, Mazurek A. Synthesis and anticancer activity evaluation of some new derivatives of 2-(4-benzoyl-1-piperazinyl)-quinoline and 2-(4-cinnamoyl-1-piperazinyl)-quinoline. Acta Poloniae Pharmaceutica - Drug Research. 2018;75(4):891-901.
  235. Witanowska J, Wroczyński P. Echoes from the past: Professor Witold Rawita-Witanowski, 1899-1945, biochemist, neurophysiologist, and pharmacologist, first editor of Acta Poloniae Pharmaceutica. Acta Poloniae Pharmaceutica - Drug Research. 2018;75(2):275-280.
  236. Ganassin R, Merkerc C, Rodrigues M, (...), Suchocki P, (...), Muehlmann L. Nanocapsules for the co-delivery of selol and doxorubicin to breast adenocarcinoma 4T1 cells in vitro. Artificial Cells Nanomedicine and Biotechnology. 2018;46(8):2002-2012.
  237. Bienias B, Michalski W, Mielan B, Pietryga K, Pamuła E, Wasek M. Ocena właściwości mechanicznych polimetakrylanu metylu zbrojonego włóknami szklanymi. Protetyka Stomatologiczna. 2018;68(1):3-15.
  238. Dąbrowska A, Pieńko T, Taciak P, Wiktorska K, Chilnonczyk Z, Mazurek A, Stasiulewicz A. Fullerene Derivatives of Nucleoside HIV Reverse Transcriptase Inhibitors-In Silico Activity Prediction. International Journal of Molecular Sciences. 2018;19(10):1-16.
  239. Giebułtowicz J, Tyski S, Wolinowska R, Grzybowska W, Zaręba T, Drobniewska A, Wroczyński P, Nałęcz-Jawecki G. Occurrence of antimicrobial agents, drug-resistant bacteria, and genes in the sewage-impacted Vistula River (Poland). Environmental Science and Pollution Research. 2018;25(6):5788-5807.
  240. Samreth D, Arnavielhe S, Ingenrieth F, (...), Samoliński B, (...), Poncelet P, MASK study group ( [grupa robocza], Lipiec A [uczestnik grupy roboczej], Szylling A [uczestnik grupy roboczej], Raciborski F [uczestnik grupy roboczej], Krzych-Fałta E [uczestnik grupy roboczej], Strozek J [uczestnik grupy roboczej], Białek S [uczestnik grupy roboczej], Wroczyński P [uczestnik grupy roboczej]. Geolocation with respect to personal privacy for the Allergy Diary app - a MASK study. World Allergy Organization Journal. 2018;11:1-13.
  241. Pawłowska A, Kocur A, Siudem P, Paradowska K. Badanie stabilności oleju lnianego i oleju z czarnuszki. Postępy Fitoterapii. 2018;19(3):157-163.
  242. Ganassin R, Horst F, Camargo N, (...), Suchocki P, (...), Muehlmann L. Selol nanocapsules with a poly(methyl vinyl ether-co-maleic anhydride) shell conjugated to doxorubicin for combinatorial chemotherapy against murine breast adenocarcinoma in vivo. Artificial Cells Nanomedicine and Biotechnology. 2018;46(suppl. 2):1046-1052.
  243. Strupińska M, Jakubowicz B, Rostafińska-Suchar G, Pirianowicz-Chaber E, Konarowska M, Mazurek A. Synthesis and study of substituted amides of some 5-membered isocyclic and heterocyclic acids as potential anticonvulsants. Acta Poloniae Pharmaceutica - Drug Research. 2018;75(3):659-667.
  244. Rużycka M, Giebułtowicz J, Wroczyński P. Present-day toxicity of smoke inhalation. Acta Poloniae Pharmaceutica - Drug Research. 2018;75(2):281-295.
  245. Bourguet E, Ozdarska K, Moroy G, Jeanblanc J, Naassila M. Class I HDAC Inhibitors: Potential New Epigenetic Therapeutics for Alcohol Use Disorder (AUD). Journal of Medicinal Chemistry. 2018;61(5):1745-1766.
  246. Somogi A, Dąbrowska A, Ziemba R, Pawiński T. Protonation of Nitrofurantoin and Furazidine Molecules in Acidic Media-Molecular Modelling Studies. Journal of In Silico & In Vitro Pharmacology. 2018;4(2):1-4.
  247. Dominiak A, Wilkaniec A, Jęśko H, Czapski G, Lenkiewicz A, Kurek E, Wroczyński P, Adamczyk A. Selol, an organic selenium donor, prevents lipopolysaccharide-induced oxidative stress and inflammatory reaction in the rat brain. Neurochemistry International. 2017;108:66-77.
  248. Kózka B, Kowalkowska A. Pochodne benzimidazolu wykazujące aktywność biologiczną. Biuletyn Wydziału Farmaceutycznego Warszawskiego Uniwersytetu Medycznego. 2017;15(3):16-33.
  249. Piotrowski R, Giebułtowicz J, Baran J, Sikorska A, Gralak-Łachowska D, Soszyńska M, Wroczyński P, Kułakowski P. Antazoline-insights into drug-induced electrocardiographic and hemodynamic effects: Results of the ELEPHANT II substudy. Annals of Noninvasive Electrocardiology. 2017;22(5):1-8.
  250. Łuszczyńska P, Pawiński T, Kunicki P, Sikorska K, Marszałek R. Free mycophenolic acid determination in human plasma ultrafiltrate by a validated liquid chromatography-tandem mass spectrometry method. Biomedical Chromatography. 2017;31(10):1-12.
  251. Rużycka M, Giebułtowicz J, Fudalej M, Krajewski P, Wroczyński P. Application of 2-aminothiazoline-4-carboxylic acid as a forensic marker of cyanide exposure. Chemical Research in Toxicology. 2017;30(2):516-523.
  252. Księżarczyk K, Sankowski B. Wybrane aspekty żywienia pozajelitowego. Biuletyn Wydziału Farmaceutycznego Warszawskiego Uniwersytetu Medycznego. 2017;(4):34-39.
  253. Zawada E, Pirianowicz-Chaber E, Somogi A, Pawiński T. Development and validation of bromatometric, diazotization and VIS-spectrophotometric methods for the determination of mesalazine in pharmaceutical formulation. Acta Poloniae Pharmaceutica - Drug Research. 2017;74(2):401-404.
  254. Giebułtowicz J, Rużycka M, Wroczyński P, Purser D, Stec A. Analysis of fire deaths in Poland and influence of smoke toxicity. Forensic Science International. 2017;277:77-87.
  255. Pieńko T, Wierzba A, Wojciechowska M, Gryko D, Trylska J. Conformational Dynamics of Cyanocobalamin and Its Conjugates with Peptide Nucleic Acids. Journal of Physical Chemistry B. 2017;121(14):2968-2979.
  256. Kłosińska-Szmurło E, Mazurek A, Grudzień M, Betlejewska-Kielak K. A New Computational Approach to the Classification of Fluoroquinolones According to the Biopharmaceutical Classification System. Current Computer-Aided Drug Design. 2017;13(1):60-74.
  257. Marszałek D, Goldnik A, Winiecka I, Jaworski P, Mazurek A. New renin inhibitors - stability and activity determination. Part IV. Acta Poloniae Pharmaceutica - Drug Research. 2017;74(2):393-399.
  258. Fijałek Z. Nowe substancje psychoaktywne - tzw. dopalacze. Kwartalnik Prawno-Kryminalistyczny. 2017;(3):9-22.
  259. Marszałek D, Goldnik A, Pawiński T, Małek G, Somogi A, Mach A. Simultaneous assay of aripiprazole and its active metabolite in serum by HPLC. Acta Poloniae Pharmaceutica - Drug Research. 2017;74(2):405-411.
  260. Rzepecka P, Duda P, Giebułtowicz J, Sochacka M, Friedman A, Gałązka-Friedman J. An example of the application of Mössbauer spectroscopy for determination of concentration of iron in lyophilized brain tissue. Nukleonika. International Journal of Nuclear Research. 2017;62(2):159-163.
  261. Gniazdowska E, Koźmiński P, Wasek M, Bajda M, Sikora J, Mikiciuk-Olasik E, Szymański P. Synthesis, physicochemical and biological studies of technetium-99m labeled tacrine derivative as a diagnostic tool for evaluation of cholinesterase level. Bioorganic & Medicinal Chemistry. 2017;25(3):912-920.
  262. Kukula K, Klopotowski M, Kunicki P, Jamiolkowski J, Debski A, Bekta P, Chmielak Z, Witkowski A. Platelet aggregation and the risk of stent thrombosis or bleeding in elective percutaneous coronary intervention patients. Blood Coagulation & Fibrinolysis. 2017;28(5):383-388.
  263. Ozdarska K, Osucha K, Savitskyi S, Malejczyk J, Galus R. Rola diety w patogenezie trądzika pospolitego. Polski Merkuriusz Lekarski. 2017;43(256):186-189.
  264. Kalicka A. Współpraca biegłego z organami ścigania w sprawach o tzw. przestępstwa farmaceutyczne Część II. Jak powstaje protokół z badań analitycznych sfałszowanych leków. Jakie informacje przekazać biegłemu, aby otrzymać dobry protokół z badań? Kwartalnik Prawno-Kryminalistyczny. 2017;(3):7-8.
  265. Pieńko T, Grudzień M, Taciak P, Mazurek A. Adsorption of Antifungal Drugs Inside Pristine and Functionalized Fullerenes and Nanotubes: DFT Investigation. Current Computer-Aided Drug Design. 2017;13(3):177-185.
  266. Wyczałkowska-Tomasik A, Czarkowska-Pączek B, Giebułtowicz J, Wroczyński P, Pączek L. Age-dependent increase in serum levels of indoxyl sulphate and p-cresol sulphate is not related to their precursors: Tryptophan and tyrosine. Geriatrics & Gerontology International. 2017;17(6):1022-1026.
  267. Strupińska M, Rostafińska-Suchar G, Jakubowicz B, Klimkiewicz P, Lal E, Oczkowski M, Próchniak E, Pirianowicz-Chaber E, Mazurek A. Synthesis and study of substituted amides of isoquinoline-3- and isoquinoline-1-carboxylic acids as potential anticonvulsants. Acta Poloniae Pharmaceutica - Drug Research. 2017;74(4):1111-1118.
  268. Chechłacz M, Korytowska N. Związki wiążące się z białkami osocza u ludzi. Znaczenie w terapii oraz metody oznaczania wolnej frakcji. Biuletyn Wydziału Farmaceutycznego Warszawskiego Uniwersytetu Medycznego. 2017;(6):50-59.
  269. Szalaj P, Tang Z, Michalski P, (...), Sadowski M, (...), Plewczyński D. An Integrated 3-Dimensional Genome Modeling Engine for data-driven simulation of spatial genome organization. Genome Research. 2016;26(12):1697-1709.
  270. Fijałek Z. New psychoactive substances - analytical challenges and threats to the public health: European and Polish experience in the new drugs combating. Macedonian pharmaceutical bulletin. 2016;(62):15-16.
  271. Giebułtowicz J, Korytowska N, Sankowski B, Wroczyński P. Development and validation of a LC-MS/MS method for quantitative analysis of uraemic toxins p-cresol sulphate and indoxyl sulphate in saliva. Talanta. 2016;150:593-598.
  272. Marszałek D, Goldnik A, Winiecka I, Jaworski P, Mazurek A. New renin inhibitors - stability and activity determination. Part III. Acta Poloniae Pharmaceutica - Drug Research. 2016;73(2):329-336.
  273. Filist M, Szlaska I, Kaza M, Pawiński T. Validated HPLC-UV method for determination of naproxen in human plasma with proven selectivity against ibuprofen and paracetamol. Biomedical Chromatography. 2016;30(6):953-961.
  274. Bierla K, Flis-Borsuk A, Suchocki P, Szpunar J, Lobinski R. Speciation of Selenium in Selenium-Enriched Sunflower Oil by High-Performance Liquid Chromatography−Inductively Coupled Plasma Mass Spectrometry/Electrospray−Orbitrap Tandem Mass Spectrometry. Journal of Agricultural and Food Chemistry. 2016;64(24):4975-4981.
  275. Zubek J, Stitzel M, Ucar D, Plewczyński D. Computational inference of H3K4me3 and H3K27ac domain length. PeerJ. 2016;4:1-12.
  276. Shipkova M, Hesselink D, Holt D, (...), Kunicki P, (...), Marquet P. Therapeutic Drug Monitoring of Everolimus: A Consensus Report. Therapeutic Drug Monitoring. 2016;38(2):143-169.
  277. Chatterjee P, Basu S, Zubek J, Kundu M, Nasipuri M, Plewczyński D. PDP-CON: prediction of domain/linker residues in protein sequences using a consensus approach. Journal of Molecular Modeling. 2016;22(4):1-15.
  278. Giebułtowicz J, Nałęcz-Jawecki G. Occurrence of immunosuppressive drugs and their metabolites in the sewage-impacted Vistula and Utrata Rivers and in tap water from the Warsaw region (Poland). Chemosphere. 2016;148:137-147.
  279. Szalaj P, Michalski P, Wróblewski P, Tang Z, Kadlof M, Mazzocco G, Ruan Y, Plewczyński D. 3D-GNOME: an integrated web service for structural modeling of the 3D genome. Nucleic Acids Research. 2016;44(1):W288-W293.
  280. Raćkowska E, Wyczałkowska-Tomasik A, Korytowska N, Pączek L. Comparison of two methods for determination of NGAL level in urine: ELISA and CMIA. Journal of Clinical Laboratory Analysis. 2016;30(6):956-960.
  281. Giebułtowicz J, Stankiewicz A, Wroczyński P, Nałęcz-Jawecki G. Occurrence of cardiovascular drugs in the sewage-impacted Vistula River and in tap water in the Warsaw region (Poland). Environmental Science and Pollution Research. 2016;23(23):24337-24349.
  282. Seger C, Shipkova M, Christians U, (...), Kunicki P, Pawiński T, (...), Wallemacq P. Assuring the Proper Analytical Performance of Measurement Procedures for Immunosuppressive Drug Concentrations in Clinical Practice: Recommendations of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology Immunosuppressive Drug Scientific Committee. Therapeutic Drug Monitoring. 2016;38(2):170-189.
  283. Cywińska M, Bystrzejewski M, Popławska M, Kośmider A, Zdanowski R, (...), Fijałek Z, (...), Bamburowicz-Klimkowska M, Cieszanowski A, Grudziński I. Internalization and cytotoxicity effects of carbon-encapsulated iron nanoparticles in murine endothelial cells Studies on internal dosages due to loaded mass agglomerates. Toxicology in Vitro. 2016;34:229-236.
  284. Giebułtowicz J, Piotrowski R, Baran J, Kułakowski P, Wroczyński P. Application of a novel liquid chromatography/tandem mass spectrometry method for the determination of antazoline in human plasma: Result of ELEPHANT-I [ELEctrophysiological, pharmacokinetic and hemodynamic effects of PHenazolinum (ANTazoline mesylate)] human pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 2016;123:113-119.
  285. Dominiak A, Wilkaniec A, Wroczyński P, Jęśko H, Adamczyk A. Protective effects of selol against sodium nitroprusside-induced cell death and oxidative stress in pc12 cells. Neurochemical Research. 2016;41(12):3215-3226.
  286. Bokota G, Magnowska M, Kuśmierczyk T, Łukasik M, Roszkowska M, Plewczyński D. Computational Approach to Dendritic Spine Taxonomy and Shape Transition Analysis. Frontiers in Computational Neuroscience. 2016;10:1-11.
  287. Savic M, Klimaszewska M, Bamburowicz-Klimkowska M, Suchocki P, Niksic M, Szutowski M, Wroczyński P, Turło J. A Search for the Optimum Selenium Source to Obtain Mushroom-Derived Chemopreventive Preparations. International Journal of Medicinal Mushrooms. 2016;18(4):279-289.
  288. Pieńko T, Grudzień M, Taciak P, Mazurek A. Cytisine basicity, solvation, logP, and logD theoretical determination as tool for bioavailability prediction. Journal of Molecular Graphics & Modelling. 2016;63:15-21.
  289. Kukula K, Klopotowski M, Kunicki P, (...), Witkowski A. Platelet aggregation and risk of stent thrombosis or bleeding in interventionally treated diabetic patients with acute coronary syndrome. BMC Cardiovascular Disorders. 2016;16(1):1-8.
  290. Giebułtowicz J, Kojro G, Piotrowski R, Kułakowski P, Wroczyński P. Cloud-point extraction is compatible with liquid chromatography coupled to electrospray ionization mass spectrometry for the determination of antazoline in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 2016;128:294-301.
  291. Kubica K, Mazurek A. Wemurafenib jako selektywny inhibitor kinazy seroninowo-treoninowej B-RAF stosowany w leczeniu czerniaka. Biuletyn Wydziału Farmaceutycznego Warszawskiego Uniwersytetu Medycznego. 2016;(8):52-56.
  292. Winiecka I, Jaworski P, Mazurek A, Marszałek D, Goldnik A, Sokulski D. Novel renin inhibitors containing derivatives of N-alkylleucyl-β-hydroxy-γ-amino acids. Journal of Peptide Science. 2016;22(2):106-115.
  293. Lubelska K, Wiktorska K, Mielczarek L, Milczarek M, Zbroińska-Bregisz I, Chilmonczyk Z. Sulforaphane Regulates NFE2L2/Nrf2-Dependent Xenobiotic Metabolism Phase II and Phase III Enzymes Differently in Human Colorectal Cancer and Untransformed Epithelial Colon Cells. Nutrition and Cancer-An International Journal. 2016;68(8):1338-1348.
  294. Czerwińska K, Wyszomirska E, Kublin E, Malanowicz E, Mazurek A. Identification and determination of rupatadine and fexofenadine by densitometric method. Acta Poloniae Pharmaceutica - Drug Research. 2016;73(6):1467-1474.
  295. Mazzocco G, Łaźniewski M, Migdał P, Szczepińska T, Radomski J, Plewczyński D. 3DFlu: database of sequence and structural variability of the influenza hemagglutinin at population scale. Database-The Journal of Biological Databases and Curation. 2016;2016:1-6.
  296. Brunet M, Shipkova M, van Gelder T, (...), Pawiński T, (...), Oellerich M. Barcelona Consensus on Biomarker-Based Immunosuppressive Drugs Management in Solid Organ Transplantation. Therapeutic Drug Monitoring. 2016;38(2S):S1-S20.
  297. Cierpiał T, Łuczak J, Kwiatkowska M, (...), Karwowska K, Mielczarek L. Organofluorine Isoselenocyanate Analogues of Sulforaphane: Synthesis and Anticancer Activity. ChemMedChem. 2016;11(21):2398-2409.
  298. Giebułtowicz J, Rużycka M, Fudalej M, Krajewski P, Wroczyński P. LC-MS/MS method development and validation for quantitative analyses of 2-aminothiazoline-4-carboxylic acid – a new cyanide exposure marker in post mortem blood. Talanta. 2016;150:586-592.
  299. Mielczarek L, Wiktorska K, Suchocki P, (...), Mielczarek S, (...), Flis A, Chilmończyk Z. The Comparison of MTT and CVS Assays for the Assessment of Anticancer Agent Interactions. PLoS One. 2016;11(5):1-17.
  300. Stypułkowska K, Błażewicz A, Fijałek Z. Analiza ilościowa antybiotyków aminoglikozydowych oraz ich zanieczyszczeń – wyzwania i nowe kierunki. Farmacja Polska. 2016;72(4):260-268.
  301. Dominiak A, Wilkaniec A, Wroczyński P, Adamczyk A. Selenium in the therapy of neurological diseases. Where is it going? Current Neuropharmacology. 2016;14(3):282-299.
  302. Flis A, Mielczarek L, Suchocka Z, Borsuk J, Fijałek Z, Suchocki P, Lubelska K. Seleninotriglicerydy nadzieją w zwalczaniu nowotworów. Biuletyn Wydziału Farmaceutycznego Warszawskiego Uniwersytetu Medycznego. 2016;(3):17-24.
  303. Stankiewicz A, Giebułtowicz J, Stankiewicz U, Wroczyński P, Nałęcz-Jawecki G. Determination of selected cardiovascular active compounds in environmental aquatic samples - Methods and results, a review of global publications from the last 10 years. Chemosphere. 2015;138:642-656.
  304. Korytowska N, Wyczałkowska-Tomasik A, Raćkowska E, Gilbert A, (...), Wroczyński P, Pączek L. Activity of Cathepsin B in Serum of Patients after Kidney Transplantation Depends on Glucocorticosteroids Treatment. Annals of Transplantation. 2015;20:622-626.
  305. Kublin E, Czerwińska K, Wyszomirska E, Zajączkowska A, Malanowicz E, Kaczmarska-Graczyk B, Mazurek A. Impact of stress factors on optical isomerism of benazepril hydrochloride. Acta Poloniae Pharmaceutica - Drug Research. 2015;72(2):219-225.
  306. Łuszczyńska P, Pawiński T. Therapeutic drug monitoring of mycophenolic acid in lupus nephrithis - a review of current literature. Therapeutic Drug Monitoring. 2015;37(6):711-717.
  307. Wasek M, Giebułtowicz J, Sochacka M, Zawada K, Modzelewska W, Krześniak L, Wroczyński P. The measurement of antioxidant capacity and polyphenol content in selected food supplements. Acta Poloniae Pharmaceutica - Drug Research. 2015;72(5):877-887.
  308. Flis A, Suchocki P, Królikowska M, Suchocka Z, (...), Mielczarek L, (...), Sochacka M, (...), Wroczyński P, Jastrzębski Z. Selenitetriglycerides-Redox-active agents. Pharmacological Reports. 2015;67(1):1-8.
  309. Ślusarczyk J, Wierzbicka M, Suchocki P, Kuraś M. Ultrastructural changes in onion (Allium cepa L.) root tip meristem cells treated with Selol and sodium selenate (IV). Caryologia. 2015;68(4):306-316.
  310. Hejchman E, Taciak P, Kowalski S, Maciejewska D, Czajkowska A, Borowska J, Śladowski D, Młynarczuk-Biały I. Synthesis and anticancer activity of 7-hydroxycoumarinyl gallates. Pharmacological Reports. 2015;67(2):236-244.
  311. Souza L, Muehlmann L, Matos L, (...), Suchocki P, (...), Azavedo R. Antitumor activity and systemic effects of PVM/MA-shelled selol nanocapsules in lung adenocarcinoma-bearing mice. Nanotechnology. 2015;26(50):1-13.
  312. Nowakowska K. Epidemiologia, klasyfikacja oraz diagnostyka czynnych i nieczynnych hormonalnie gruczolaków przysadki. Biuletyn Wydziału Farmaceutycznego Warszawskiego Uniwersytetu Medycznego. 2015;(6):40-45.
  313. Ganassin R, Souza L, Rapp-Py K, (...), Suchocki P, (...), Muehlmann L. Poly(methyl vinyl ether-co-maleic anhydride)-shelled selol nanocapsules conjugated to folic acid: development and in vitro activity against lung adenocarcinoma A549 cells. Journal of Nanomedicine & Nanotechnology. 2015;6(6):1-6.
  314. Kunicki P, Pawiński T, Boczek A, Waś J, Bodnar-Broniarczyk M. A comparison of the immunochemical methods, PETINIA and EMIT with that of HPLC-UV for the routine monitoring of mycophenolic acid in heart transplant patients. Therapeutic Drug Monitoring. 2015;37(3):311-318.
  315. Chodkowski A, Wróbel M, Turło J, Kleps J, (...), Mazurek A, Herold F. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity. Part 4. European Journal of Medicinal Chemistry. 2015;90:21-32.
  316. Luliński P, Giebułtowicz J, Wroczyński P, Maciejewska D. A highly selective molecularly imprinted sorbent for extraction of 2-aminothiazoline-4-carboxylic acid – Synthesis, characterization andapplication in post-mortem whole blood analysis. Journal of Chromatography A. 2015;1420:16-25.
  317. Giebułtowicz J, Kojro G, Buś-Kwaśnik K, Rudzki P, Marszałek R, Leś A, Wroczyński P. Cloud-point extraction is compatible with liquid chromatography coupled to electrospray ionization mass spectrometry for the determination of bisoprolol in human plasma. Journal of Chromatography A. 2015;1423:39-46.
  318. Stankiewicz A, Giebułtowicz J, Stefański M, Czaplicka K, Wroczyński P, Nałęcz-Jawecki G. The development of the LC-MS/MS method based on S-9 biotransformation for detection of metabolites of selected β-adrenolytics in surface water. Environmental Toxicology and Pharmacology. 2015;39(2):906-916.
  319. Majcher A, Lewandrowska A, Herold F, Stefanowicz J, Słowiński T, Mazurek A, Wieczorek S, Hołyst R. A method for rapid screening of interactions of pharmacologically active compounds with albumin. Analytica Chimica Acta. 2015;855:51-59.
  320. Stypułkowska K, Błażewicz A, Brudzikowska A, Warowna-Grześkiewicz M, Sarna K, Fijałek Z. Development of high performance liquid chromatography methods with charged aerosol detection for the determination of lincomycin, spectinomycin and its impurities in pharmaceutical products. Journal of Pharmaceutical and Biomedical Analysis. 2015;112:8-14.
  321. Chodnicka D, Giebułtowicz J, Chomicz L, Wroczyński P. Ocena aktywności S-transferazy, peroksydazy glutationowej oraz pojemności antyoksydacyjnej u pacjentów z bąblowicą jednojamową. Diagnostyka Laboratoryjna. 2015;51(1):31-36.
  322. Strupińska M, Rostafińska-Suchar G, Pirianowicz-Chaber E, Grabarczuk M, Józwenko M, Kowalczyk H, Szuba J, Wójcicka M, (...), Mazurek A. Synthesis and study of halogenated benzylamides of some isocyclic and heterocyclic acids as potential anticonvulsants. Acta Poloniae Pharmaceutica - Drug Research. 2015;72(3):489-496.
  323. Śledź J. Nowotwory jamy ustnej - dane epidemiologiczne i czynniki ryzyka zachorowania. Biuletyn Wydziału Farmaceutycznego Warszawskiego Uniwersytetu Medycznego. 2015;(2):6-12.
  324. Pieńko T, Taciak P, Mazurek A. On Basicity of 8-phenylsulphanyl Quipazine Derivatives - New Potential Serotonergic Agents. Journal of Physical Chemistry A. 2015;119(27):6989-6999.
  325. de Souza L, Muehlmann L, Costa dos Santos M, (...), Suchocki P, (...), Báo S. PVM/MA-shelled selol nanocapsules promote cell cycle arrest in A549 lung adenocarcinoma cells. Journal of Nanobiotechnology. 2014;12(1):1-17.
  326. Piórkowska E, Kaza M, Fitatiuk J, Szlaska I, Pawiński T, Rudzki P. Rapid and simplified HPLC-UV method with on-line wavelengths switching for determination of capecitabine in human plasma. Pharmazie. 2014;69(7):500-505.
  327. Lisowska-Kuźmicz M, Kantor-Boruta M, Jończyk A, Jarończyk M, Ocios-Bębenek A, Mazurek A, Chilmonczyk Z, Jarosz M. New validated HPLC methodology for the determination of (-)-trans-paroxetine and its enantiomer in pharmaceutical formulations with use of ovomucoid chiral stationary phase. Analytical and Bioanalytical Chemistry. 2014;406(15):3697-3702.
  328. Grembecka M, Baran P, Błażewicz A, Fijałek Z, Szefer P. Simultaneous determination of aspartame, acesulfame-K, saccharin, citric acid and sodium benzoate in various food products using HPLC–CAD–UV/DAD. European Food Research and Technology. 2014;238(3):357-365.
  329. Luliński P, Kalny P, Giebułtowicz J, Maciejewska D, Wroczyński P. Synthesis and characterization of cadmium(II)-imprinted poly(1-allyl-2-thiourea-co-ethylene glycol dimethacrylate) particles for selective separation. Polymer Bulletin. 2014;71(7):1727-1741.
  330. Podolska M, Kulik A, Białecka W, Kwiatkowska-Puchniarz B, Mazurek A. HPLC method for identification and quantification of three active substances in a dermatological preparation - Viosept ointment. Acta Poloniae Pharmaceutica - Drug Research. 2014;71(5):709-719.
  331. Giebułtowicz J, Nałęcz-Jawecki G. Occurrence of antidepressant residues in the sewage-impacted Vistula and Utrata rivers and in tap water in Warsaw (Poland). Ecotoxicology and Environmental Safety. 2014;104:103-109.
  332. Winiecka I, Marszałek D, Goldnik A, Jaworski P, Mazurek A. Novel renin inhibitors containing a non-peptide aminoalkanoyl moiety at P1-P1′ position. Pharmazie. 2014;69(4):263-270.
  333. Ślusarczyk J, Dudek M, Wierzbicka M, Suchocki P, Kuraś M. Antimitotic effect of Selol and sodium selenate (IV) on Allium test cells. Caryologia. 2014;67(3):250-259.
  334. Pokrywka A, Obmiński Z, Malczewska-Lenczowska J, Fijałek Z, Turek-Lepa E, Grucza R. Insights into Supplements with Tribulus Terrestris used by Athletes. Journal of Human Kinetics. 2014;41:99-105.
  335. Biernacka J, Betlejewska-Kielak K, Witowska-Jarosz J, Kłosińska-Szmurło E, Mazurek A. Mass spectrometry and molecular modeling studies on the inclusion complexes between alendronate and β-cyclodextrin. Journal of Inclusion Phenomena and Macrocyclic Chemistry. 2014;78(1):437-443.
  336. Kłosińska-Szmurło E, Grudzień M, Betlejewska-Kielak K, Pluciński F, Biernacka J, Mazurek A. Physicochemical properties of lomefloxacin, levofloxacin, and moxifloxacin relevant to the biopharmaceutics classification system. Acta Chimica Slovenica. 2014;61(4):827-834.
  337. Grudzień M, Suskiewicz M, Ajmanovič E, Pluciński F, Mazurek A. Fullerenes as the carriers of compounds with amide bond. Acta Poloniae Pharmaceutica - Drug Research. 2014;71(6):1073-1078.
  338. Kaza M, Gilant E, Filist M, Szlaska I, Pawiński T, Rudzki P. Determination of duloxetine in human plasma with proven lack of influence of the major metabolite 4-hydroxyduloxetine. Clinical Biochemistry. 2014;47(13-14):1313-1315.
  339. Marszałek D, Goldnik A, Mazurek A, Winiecka I, Jaworski P. New renin inhibitors - Stability and activity determination. Part I. Acta Poloniae Pharmaceutica - Drug Research. 2014;71(4):545-553.
  340. Giebułtowicz J, Sołobodowska S, Bobilewicz D, Wroczyński P. Blood ALDH1 and GST activity in diabetes type 2 and its correlation with glycated hemoglobin. Experimental and Clinical Endocrinology and Diabetes. 2014;122(1):55-59.
  341. Wasek M, Wroczyński P, Sołobodowska S, Szewczak K, Jarosz Z. Measurement of the radioactivity of 137Cs in materials of plant origin with potential radioactive contamination. Acta Poloniae Pharmaceutica - Drug Research. 2014;71(6):1114-1118.
  342. Urbańska N, Giebułtowicz J, Olszowska O, Szypuła W. The growth and saponin production of Platycodon grandiflorum (Jacq.) A. DC. (Chinese bellflower) hairy roots cultures maintained in shake flasks and mist bioreactor. Acta Societatis Botanicorum Poloniae. 2014;83(3):229-237.
  343. Książek I, Sitarz K, Rosłon M, Anuszewska E, Hoser G, Dudkiewicz Wilczyńska J, Iwanowska M, Suchocki P. The influence of an organic selenium (IV) compound on progression of tumour induced using prostate cancer cells and gene expression connected to the oxidative stress response. World Journal of Pharmaceutical Sciences. 2014;2(10):1146-1158.
  344. Dudkiewicz-Wilczyńska J, Grabowska A, Książek I, Sitarz K, Suchocki P, Anuszewska E. Comparison of selected gene expression profiles in sensitive and resistant cancer cells treated with doxorubicin and Selol. Współczesna Onkologia-Contemporary Oncology. 2014;18(2):90-94.
  345. Kłosińska-Szmurło E, Pluciński F, Grudzień M, Betlejewska-Kielak K, Biernacka J, Mazurek A. Experimental and theoretical studies on the molecular properties of ciprofloxacin, norfloxacin, pefloxacin, sparfloxacin, and gatifloxacin in determining bioavailability. Journal of Biological Physics. 2014;40(4):335-345.
  346. Sochacka M, Giebułtowicz J, Remiszewska M, Suchocki P, Wroczyński P. Effects of Selol 5% supplementation on the activity or concentration of antioxidants and malondialdehyde level in the blood of healthy mice. Pharmacological Reports. 2014;66(2):301-310.
  347. Winiecka I, Marszałek D, Goldnik A, Jaworski P, Mazurek A. New renin inhibitors containing phenylalanylhistidyl-γ-amino acid derivatives in P3 - P1' position. Acta Poloniae Pharmaceutica - Drug Research. 2014;71(1):59-69.
  348. Marszałek D, Goldnik A, Mazurek A, Balicka M, Koziorowska A, Hermanowicz A, Łuka M, Piątkowska M, Grodzka S, Kumorowska S. Stability of new anticonvulsant derivatives of picolinic, nicotinic, cyclocarboxylic acids in body fluids and tissues. Acta Poloniae Pharmaceutica - Drug Research. 2014;71(2):261-264.
  349. Grudziński I, Bystrzejewski M, Cywińska M, Kośmider A, Popławska M, Cieszanowski A, Fijałek Z, Ostrowska A. Comparative cytotoxicity studies of carbon-encapsulated iron nanoparticles in murine glioma cells. Colloids and Surfaces B: Biointerfaces. 2014;117:135-143.
  350. Marszałek D, Goldnik A, Mazurek A, Winiecka I, Jaworski P, Szerszań S, Kozikowska E, Pawlik T. New renin inhibitors - Stability and activity determination. Part II. Acta Poloniae Pharmaceutica - Drug Research. 2014;71(4):555-561.
  351. Grudziński I, Bystrzejewski M, Cywińska M, Kośmider A, Popławska M, Cieszanowski A, Fijałek Z, (...), Parzonko A. Assessing carbon-encapsulated iron nanoparticles cytotoxicity in Lewis lung carcinoma cells. Journal of Applied Toxicology. 2014;34(4):380-394.
  352. Popławska M, Błażewicz A, Żołek P, Fijałek Z. Determination of flibanserin and tadalafil in supplements for women sexual desire enhancement using high-performance liquid chromatography with tandem mass spectrometer, diode array detector and charged aerosol detector. Journal of Pharmaceutical and Biomedical Analysis. 2014;94:45-53.
  353. Gralak-Dąbrowska B, Pawiński T, Pulik P, Horban A. Interpatient variability of darunavir concentrations in plasma during long-term antiretroviral monotherapy. HIV and AIDS Review. 2014;13(1):10-13.
  354. Książek I, Sitarz K, Anuszewska E, Dudkiewicz-Wilczyńska J, Rosłon M, Koronkiewicz M, Suchocki P. Toxicity studies of Selol – An organic selenium (IV) compound – in vitro research. International Journal of Pharmacy and Pharmaceutical Sciences. 2014;6(5):264-269.
  355. Mędrek M, Pluciński F, Mazurek A. Energetic barrier for penetration of N, N and N through the centre of hexagonal rings of a C60 cage. A stability study of the endohedral complexes (N@C60, N @C 60 and N @C60). Micro & Nano Letters. 2014;9(6):425-428.
  356. Słowiński T, Stefanowicz J, Wróbel M, Herold F, Mazurek A, Pluciński F, Mazurek A, Wolska I. Model structure-activity relationship studies of potential tropane 5HT1A, 5HT2A, and D2 receptor ligands. Medicinal Chemistry Research. 2013;22(7):3148-3153.
  357. Wyszomirska E, Czerwińska K, Kublin E, Mazurek A. Identification and determination of ketotifen hydrogen fumarate, azelastine hydrochloride, dimetindene maleate and promethazine hydrochloride by densitometric method. Acta Poloniae Pharmaceutica - Drug Research. 2013;70(6):951-959.
  358. Popławska M, Błażewicz A, Bukowińska K, Fijałek Z. Application of high-performance liquid chromatography with charged aerosol detection for universal quantitation of undeclared phosphodiesterase-5 inhibitors in herbal dietary supplements. Journal of Pharmaceutical and Biomedical Analysis. 2013;84:232-243.
  359. Sadlej-Sosnowska N, Mazurek A. Distribution of electron density in charged Li@C60 complexes. Chemical Physics Letters. 2013;580:53-56.
  360. Strupińska M, Rostafińska-Suchar G, Pirianowicz-Chaber E, Stables J, Jiang J, Paruszewski R. Synthesis and research of benzylamides of some isocyclic and heterocyclic acids as potential anticonvulsants. Acta Poloniae Pharmaceutica - Drug Research. 2013;70(4):681-686.
  361. Grech-Baran M, Sykłowska-Baranek K, Giebułtowicz J, Wroczyński P, Pietrosiuk A. Tyrosol Glucosyltransferase Activity and Salidroside Production in Natural and Transformed Root Cultures of Rhodiola Kirilowii (Regel) Regel et Maximowicz. Acta Biologica Cracoviensia. Series Botanica. 2013;55(2):126-133.
  362. Wróbel M, Chodkowski A, Herold F, Gomółka A, Kleps J, Mazurek A, (...), Turło J. Synthesis and biological evaluation of novel pyrrolidine-2,5-dione derivatives as potential antidepressant agents. Part 1. European Journal of Medicinal Chemistry. 2013;63:484-500.
  363. Książek I, Sitarz K, Rosłon M, Anuszewska E, Suchocki P, Dudkiewicz-Wilczyńska J. The influence of Selol on the expression of oxidative stress genes in normal and malignant prostate cells. Cancer Genomics & Proteomics. 2013;10(5):225-232.
  364. Czerwińska K, Wyszomirska E, Mazurek A. Identification and determination of selected histamine antagonists by densitometric method. Acta Poloniae Pharmaceutica - Drug Research. 2013;70(1):19-26.
  365. Giebułtowicz J, Wroczyński P, Kosiński P, Pietrzak B. The activity of salivary aldehyde dehydrogenase during the menstrual cycle and pregnancy. Archives of Oral Biology. 2013;58(3):261-265.
  366. Biernacka J, Batlejewska-Kielak K, Kłosińska-Szmurło E, Pluciński F, Mazurek A. Prediction of bioavailability of selected bisphosphonates using in silico methods towards categorization into biopharmaceutical classification system. Acta Poloniae Pharmaceutica - Drug Research. 2013;70(5):877-882.
  367. Binkowska-Bury M, Januszewicz P, Wolan M, Sobolewski M, Krauze M, Fijałek Z. Counterfeit medicines in Poland: opinions of primary healthcare physicians, nurses and lay persons. Journal of Clinical Nursing. 2013;22(3-4):559-568.
  368. Fijałek Z, Sarna K. Farmacja po kryzysie heparynowym - czy możliwa jest skuteczna ochrona pacjentów przed standardowymi i sfałszowanymi produktami? Farmacja Polska. 2013;69(1):26-31.
  369. Białecka W, Kulik A, Podolska M, Kwiatkowska-Puchnairz B, Mazurek A. Purity determination of Gynalgin bactericidal tablets with HPLC method. Acta Poloniae Pharmaceutica - Drug Research. 2013;70(1):51-58.
  370. Granica S, Kiss A, Jarończyk M, Maurin J, Mazurek A, Czarnocki Z. Synthesis of Imperatorin Analogs and Their Evaluation as Acetylcholinesterase and Butyrylcholinesterase Inhibitors. Archiv der Pharmazie. 2013;346(11):775-782.
  371. Stypułkowska K, Błażewicz A, Fijałek Z, Warowna-Grześkiewicz M, Srebrzyńska K. Determination of neomycin and related substances in pharmaceutical preparations by reversed-phase high performance liquid chromatography with mass spectrometry and charged aerosol detection. Journal of Pharmaceutical and Biomedical Analysis. 2013;76:207-214.
  372. Wasek M, Wroczyński P, Sołobodowska S, Lal N. The analysis of plant-based raw materials of unknown origin. Acta Poloniae Pharmaceutica - Drug Research. 2013;70(2):371-375.
  373. Grudzień M, Pałka K, Pluciński F, Mazurek A. Molecular properties impact on bioavailability of second generation triazoles antifungal agents. Acta Poloniae Pharmaceutica - Drug Research. 2013;70(5):869-872.
  374. Giebułtowicz J, Wroczyński P, Samolczyk-Wanyura D. Can lower aldehyde dehydrogenase activity in saliva be a risk factor for oral cavity cancer? Oral Diseases. 2013;19(8):763-766.
  375. Pawiński T, Łuszczyńska P, Durlik M, Majchrzak J, Bączkowska T, (...), Kamińska D, (...), Klinger M. Development and Validation of Limited Sampling Strategies for the Estimation of Mycophenolic Acid Area Under the Curve in Adult Kidney and Liver Transplant Recipients Receiving Concomitant Enteric-Coated Mycophenolate Sodium and Tacrolimus. Therapeutic Drug Monitoring. 2013;35(6):760-769.
  376. Mędrek M, Pluciński F, Mazurek A. Endohedral complexes of fullerene C60 with small convalent molecules (H2O, NH3, H2, 2H2, 3H2, 4H2, O2, O3) in the context of potential drug transporter system. Acta Poloniae Pharmaceutica - Drug Research. 2013;70(4):659-665.
  377. Giebułtowicz J, Polańska-Płachta M, Wroczyński P, Zaborowski P, Polański J. How echinoccocosis affects potential cancer markers in plasma: galectin-3, sN-cadherin and sE-cadherin? A preliminary report. Diagnostic Pathology. 2012;7:1-5.
  378. Sadlej-Sosnowska N, Mazurek A. Electron Density Distribution in Endohedral Complexes of Fullerene C50, Calculated Based on the Gauss Law. Journal of Chemical Information and Modeling. 2012;52(5):1193-1198.
  379. Binkowska-Bury M, Wolan M, Januszewicz P, Mazur A, Fijałek Z. What Polish hospital healthcare workers and lay persons know about counterfeit medicine products? Central European Journal of Public Health. 2012;20(4):276-281.
  380. Elhissi A, Giebułtowicz J, Stec A, Wroczyński P, Ahmed W, Alhnan M, Phoenix D, Taylor K. Nebulization of ultradeformable liposomes: the influence of aerosolization mechanism and formulation excipients. International Journal of Pharmaceutics. 2012;436(1-2):519-526.
  381. Estevanato L, Da Silva J, Falqueiro A, Mosiniewicz-Szablewska E, Suchocki P, Tedesco A, Morais P, Lacava Z. Co-nanoencapsulation of magnetic nanoparticles and selol for breast tumor treatment: in vitro evaluation of cytotoxicity and magnetohyperthermia efficacy. International Journal of Nanomedicine. 2012;7:5287-5299.
  382. Falqueiro A, Siqueira-Moura M, Jardim D, Primo F, Morais P, Mosiniewicz-Szablewska E, Suchocki P, Tedesco A. In vitro cytotoxicity of Selol-loaded magnetic nanocapsules against neoplastic cell lines under AC magnetic field activation. Journal of Applied Physics. 2012;111(7):B335-1-B335-3.
  383. Marszałek D, Goldnik A, Pluciński F, Mazurek A, Jakubiak A, Lis E, Tazbir P, Koziorowska A. Metabolic stability of new anticonvulsants in body fluids and organ homogenates. Acta Poloniae Pharmaceutica - Drug Research. 2012;69(1):47-51.
  384. Karpińska G, Mazurek A, Dobrowolski J. On substituent effect on the benzodiazepinone system. Computational and Theoretical Chemistry. 2012;993:13-19.
  385. Łozak A, Sołtyk K, Kiljan M, Fijałek Z, Ostapczuk P. Determination of Selected Trace Elements in Dietary Supplements Containing Plant Materials. Polish Journal of Food and Nutrition Sciences. 2012;62(2):97-102.
  386. Wasek M, Szewczak K, Wroczyński P. Exposure to ionizing radiation of workers in Poland. Acta Poloniae Pharmaceutica - Drug Research. 2012;69(6):1387-1389.
  387. Jadach M, Błażewicz A, Fijałek Z. Determination of local anesthetics in illegal products using HPLC method with amperometric detection. Acta Poloniae Pharmaceutica - Drug Research. 2012;69(3):397-403.
  388. Sołobodowska S, Giebułtowicz J, Wolinowska R, Wroczyński P. Contribution of ALDH1A1 isozyme to detoxification of aldehydes present in food products. Acta Poloniae Pharmaceutica - Drug Research. 2012;69(6):1380-1383.
  389. Figurski M, Pawiński T, Goldberg L, (...), Shaw L. Pharmacokinetic monitoring of mycophenolic acid in heart transplant patients: correlation the side-effects and rejections with pharmacokinetic parameters. Annals of Transplantation. 2012;17(1):68-78.
  390. Kantor-Boruta M, Lisowska-Kuźmicz M, Jończyk A, (...), Mazurek A, (...), Jarosz M. The new HPLC methodology for the chiral separation of tamsulosin enantiomers on amylose tris(3,5-dimethylphenylcarbamate) stationary phase. Talanta. 2012;102:75-78.
  391. Kublin E, Malanowicz E, Kaczmarska-Graczyk B, Mazurek A. Development of chromatographic method for determination of drugs reducing cholesterol level. Acta Poloniae Pharmaceutica - Drug Research. 2012;69(1):139-143.
  392. Jaronczyk M, Wołosewicz K, Gabrielsen M, (...), Mazurek A, (...), Chilmonczyk Z. Synthesis, in vitro binding studies and docking of long-chain arylpiperazine nitroquipazine analogues, as potential serotonin transporter inhibitors. European Journal of Medicinal Chemistry. 2012;49:200-210.
  393. Kunicki P, Pawiński T. Równoważność biologiczna preparatów generycznych leków immunosupresyjnych - różnice farmakokinetyczne i konsekwencje dla terapii monitorowanej stężeniem leku. Nefrologia i Dializoterapia Polska. 2012;16(4):181-186.
  394. Kalny P, Wyderska S, Fijałek Z, Wroczyński P. Determination of selected elements in different pharmaceutical forms of some Polish herbal medicinal products. Acta Poloniae Pharmaceutica - Drug Research. 2012;69(2):279-283.
  395. Fijałek Z, Sarna K, Błażewicz A, Maurin J, Baran P, Wacławek K. Counterfeit medicinal products, medical devices and dietary supplements – growing safety risks for public health. Military Pharmacy and Medicine. 2011;4(4):29-38.
  396. PODOLSKA M, Białecka W, Kulik A, Kwiatkowska-Puchniarz B, Mazurek A. Determination of sodium metabisulfite in parenteral formulations by HPIC with suppressed conductivity detection. Acta Poloniae Pharmaceutica - Drug Research. 2011;68(5):637-644.
  397. Herold F, Chodkowski A, Izbicki Ł, Turło J, Dawidowski M, Kleps J, (...), Mazurek A, (...), Pluciński F. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity. part 3. European Journal of Medicinal Chemistry. 2011;46(1):142-149.
  398. Mazurek A, Sadlej-Sosnowska N. Is fullerene C60 large enough to host an aromatic molecule? International Journal of Quantum Chemistry. 2011;111(10):2398-2405.
  399. Falqueiro A, Primo F, Morais P, Mosiniewicz-Szablewska E, Suchocki P, Tedesco A. Selol-loaded magnetic nanocapsules: A new approch for hyperthermia cancer therapy. Journal of Applied Physics. 2011;109(7):1-3.
  400. Kulik A, Białecka W, PODOLSKA M, Kwiatkowska-Puchniarz B, Mazurek A. HPLC method for identification and quantification of benzimidazole derivatives in antiparasitic drugs. Acta Poloniae Pharmaceutica - Drug Research. 2011;68(6):823-829.
  401. Stypułkowska K, Błażewicz A, Maurin J, Sarna K, Fijałek Z. X-ray powder diffractometry and liquid chromatography studies of sibutramine and its analogues content in herbal dietary supplements. Journal of Pharmaceutical and Biomedical Analysis. 2011;56(5):969-975.
  402. Venhuis B, Vredenbregt M, Kaun N, Maurin J, Fijałek Z, de Kaste D. The identification of rimonabant polymorphs, sibutramine and analogues of both in counterfeit Acomplia bought on the internet. Journal of Pharmaceutical and Biomedical Analysis. 2011;54(1):21-26.
  403. Karpińska G, Mazurek A, Dobrowolski J. Hydroxyquinolines: Constitutional isomers and tautomers. Computational and Theoretical Chemistry. 2011;972(1-3):48-56.
  404. Kulik A, SZCZOTKOWSKA A, Białecka W, PODOLSKA M, Kwiatkowska-Puchniarz B, Mazurek A. Determination of active substances in binary mixture antiparasitic veterinary formulations by HPLC. Acta Poloniae Pharmaceutica - Drug Research. 2011;68(4):467-472.
  405. Dudkiewicz-Wilczyńska J, Książek I, NOWAK K, Suchocki P, Flis S, Kiljan M, ANUSZEWSKA E. Badania wpływu Selolu i seleninu sodu na komórki HeLa in vitro. Chemik. Nauka, Technika, Rynek. 2011;65(2):105-114.
  406. Słowiński T, Stefanowicz J, Dawidowski M, Kleps J, (...), Mazurek A, Mazurek A, (...), Herold F. Synthesis and biological investigation of potential atypical antipsychotics with a tropane core. Part 1. European Journal of Medicinal Chemistry. 2011;46(9):4474-4488.
  407. Giebułtowicz J, Wroczyński P, Samolczyk-Wanyura D. Comparison of antioxidant enzymes activity and the concentration of uric acid in the saliva of patients with oral cavity cancer, odontogenic cysts and healthy subjects. Journal of Oral Pathology & Medicine. 2011;40(9):726-730.
  408. Czerwińska K, Mazurek A. Identification and determination of selected angiotensin II receptor antagonist group drugs by HPLC method. Acta Poloniae Pharmaceutica - Drug Research. 2011;68(6):831-837.
  409. Kublin E, Kaczmarska-Graczyk B, Malanowicz E, Mazurek A. Methods of chromatographic determination of medicines decreasing the level of cholesterol. Acta Poloniae Pharmaceutica - Drug Research. 2010;67(5):455-461.
  410. Giebułtowicz J, Wroczyński P, Wierzchowski J. Salivary aldehyde dehydrogenase activity – Influence of drugs intake, preliminary research. Acta Poloniae Pharmaceutica - Drug Research. 2010;67(6):615-619.
  411. Anyżewska M, Kowalczuk A, Łozak A, Jabłczyńska R, Fijałek Z. Determination of total hypericins in St. John’s wort and herbal medicinal products. Acta Poloniae Pharmaceutica - Drug Research. 2010;67(6):586-592.
  412. Błażewicz A, Fijałek Z, Warowna-Grześkiewicz M, Jadach M. Determination of atracurium, cisatracurium and mivacurium with their impurities in pharmaceutical preparations by liquid chromatography with charged aerosol detection. Journal of Chromatography A. 2010;1217(8):1266-1272.
  413. Fijałek Z, Sarna K, Błażewicz A, Marin J. Sfałszowane inhibitory fosfodiesterazy typu 5 - narastające zagrożenie dla zdrowia publicznego. Roczniki Państwowego Zakładu Higieny. 2010;61(3):227-235.
  414. Błażewicz A, Fijałek Z, Sarna K, Warowna-Grześkiewicz M. Determination of Pancuronium and Its Impurities in Pharmaceutical Preparation by LC with Charged Aerosol Detection. Chromatographia. 2010;72(1-2):183-186.
  415. Wyszomirska E, Czerwińska K, Mazurek A. Identification and determination of antihypertonics from the group of angiotensin-convertase inhibitors by densitometric method in comparition with HPLC method. Acta Poloniae Pharmaceutica - Drug Research. 2010;67(2):137-143.
  416. Rahden-Staroń I, Suchocki P, Czeczot H. Evaluation of mutagenic activity of the organo-selenium compound Selol by use of the Salmonella typhimurium mutagenicity assay. Mutation Research-Genetic Toxicology and Environmental Mutagenesis. 2010;699(1-2):44-46.
  417. Pawiński T. Terapeutyczne monitorowanie stężeniem kwasu mykofenolowego w terapii immunosupresyjnej – zalecenia i wątpliwości. Reaktywacja: magazyn dla lekarzy transplantologów. 2010;(3):12-15.
  418. Pawiński T. Therapeutic drug monitoring of mycophenolic acid: a potential treatment for lupus nephritis. Kidney International. 2010;78(4):335-336.
  419. Giebułtowicz J, Dziadek M, Wroczyński P, Woźnicka K, Wojno B, Pietrzak M, Wierzchowski J. Salivary aldehyde dehydrogenase — temporal and population variability, correlations with drinking and smoking habits and activity towards aldehydes contained in food. Acta Biochimica Polonica. 2010;57(3):361-368.
  420. Stypulkowska K, Blazewicz A, Fijałek Z, Sarna K. Determination of Gentamicin Sulphate Composition and Related Substances in Pharmaceutical Preparations by LC with Charged Aerosol Detection. Chromatographia. 2010;72(11-12):1225-1229.
  421. Turło J, Gutkowska B, Herold F, Klimaszewska M, Suchocki P. Optimization of Selenium-Enriched Mycelium of Lentinula edodes (Berk.) Pegler as a Food Supplement. Food Biotechnology. 2010;24(2):180-196.
  422. Winiecka I, Dudkiewicz-Wilczyńska J, Roman I, Paruszewski R. New potential renin inhibitors with dipeptide replacements in the molecule. Acta Poloniae Pharmaceutica - Drug Research. 2010;67(4):367-374.
  423. Giebułtowicz J, Wolinowska R, Sztybor A, Pietrzak M, Wroczyński P, Wierzchowski J. Salivary aldehyde dehydrogenase: activity towards aromatic aldehydes and comparison with recombinant ALDH3A1. Molecules. 2009;14(7):2363-2372.
  424. Pawiński T, Kunicki P, Sobieszczanska-Malek M, Gralak B, Szlaska I. A limited sampling strategy for estimating mycophenolic acid area under the curve in adult heart transplant patients treated with concomitant cyclosporine. Journal of Clinical Pharmacy and Therapeutics. 2009;34(1):89-101.
  425. Bogucka M, Giebułtowicz J, Zawada K, Wroczyński P, Wierzchowski J, Pietrzak M, Piekarczyk P, Romanowska K. The oxidation status of ALDH3A1 in human saliva and its correlation with antioxidant capacity measured by ORAC method. Acta Poloniae Pharmaceutica - Drug Research. 2009;66(5):477-482.
  426. Grudzień M, Król A, Paterek G, Stępień K, Pluciński F, Mazurek A. The structure-bioavailability approach in antifungal agents. European Journal of Medicinal Chemistry. 2009;44(5):1978-1981.
  427. Żero P, Pluciński F, Mazurek A. Theoretical comparison of molecular properties of linear and cyclic glycine derived peptides and their phosphor analogues. Journal of Molecular Structure-Theochem. 2009;915(1-3):182-187.
  428. Turło J, Gutkowska B, Herold F, Łuczak-Zielkiewicz I. Investigation of the kinetics of selenium accumulation by Lentinula edodes (Berk.) mycelial culture by use of reversed-phase high-performance liquid chromatography with fluorimetric detection. Acta Chromatographica. 2009;21(1):1-11.
  429. Malinowska E, Krzyczkowski W, Herold F, Łapienis G, Ślusarczyk J, Suchocki P, Kuraś M, Turło J. Biosynthesis of selenium-containing polysaccharides with antioxidant activity in liquid culture of Hericium erinaceum. Enzyme and Microbial Technology. 2009;44(6):334-343.
  430. Urbańska N, Nartowska J, Skorupska A, Roszkowski D, Giebułtowicz J, Olszowska O. Determination and haemolytic activity of saponins in hairy root culture of Platycodon grandiflorum A.DC. Herba Polonica. 2009;55(3):103-108.
  431. Krzyczkowski W, Malinowska E, Suchocki P, Kleps J, Olejnik M, Herold F. Isolation and quantitative determination of ergosterol peroxide in various edible mushroom species. Food Chemistry. 2009;113(1):351-355.
  432. Strupińska M, Rostafińska-Suchar G, Stables J, Paruszewski R. New derivatives of benzylamide with anticonvulsant activity. Acta Poloniae Pharmaceutica - Drug Research. 2009;66(2):155-159.
  433. Jeziorek M, Wasek M. Free radical scavenging activity for infusions of 30 medicinal plants detected with Electron Paramagnetic Resonance. Herba Polonica. 2008;54(1):7-14.
  434. Grudzień M, Gajewska A, Pluciński F, Mazurek A. Molecular Properties Relevant To Bioavailability of Tioconazole and Its Derivatives. Acta Poloniae Pharmaceutica - Drug Research. 2008;65(6):757-758.
  435. Błażewicz A, Fijałek Z, Warowna-Grześkiewicz M, Banasiuk J. Application of high-performance liquid chromatography with amperometric and coulometric detection to the analysis of SZ1677, a new neuromuscular blocking agent, and its two derivatives. Journal of Chromatography A. 2008;1204(1):114-118.
  436. Grudzień M, Krakowiak N, Pluciński F, Mazurek A. Molecular properties of oxyconazole and tioconazole as the criteria for their bioavailability estimation. Acta Poloniae Pharmaceutica - Drug Research. 2008;65(1):123-124.
  437. Paradowska K, Wolniak M, Fijałek Z, Wawer I. Identification and analysis of drugs in the solid state by 13C CPMAS NMR: suxamethonium chloride and hydrocortisonum (corhydron). Acta Poloniae Pharmaceutica - Drug Research. 2008;65(3):295-301.
  438. Pawiński T, Pulik P, Gralak B, Horban A. Pharmacokinetic Monitoring of HIV-1 Protease Inhibitors in The Antiretroviral Therapy. Acta Poloniae Pharmaceutica - Drug Research. 2008;65(1):93-100.
  439. Grosicka-Maciąg E, Kurpios D, Czeczot H, Szumiło M, Skrzycki M, Suchocki P, Rahden-Staroń I. Changes in antioxidant defense systems induced by thiram in V79 Chinese hamster fibroblasts. Toxicology in Vitro. 2008;22(1):28-35.
  440. Błażewicz A, Fijałek Z, Samsel K. Determination of pipecuronium bromide and its impurities in pharmaceutical preparation by high-performance liquid chromatography with coulometric electrode array detection. Journal of Chromatography A. 2008;1201(2):191-195.
  441. Błażewicz A, Fijałek Z, Warowna-Grześkiewicz M, Boruta M. Simultaneous determination of rocuronium and its eight impurities in pharmaceutical preparation using high-performance liquid chromatography with amperometric detection. Journal of Chromatography A. 2007;1149(1):66-72.
  442. Herold F, Kałucka M, Król M, Herold J, Kleps J, Turło J. Synthesis of a new scaffold: the 7H,8H-pyrimido[1,6-b]pyridazin-6,8-dione nucleus. Molecules. 2007;12(12):2643-2657.
  443. Suchocki P, Misiewicz I, Skupińska K, Wacławek K, Fijałek Z, Kasprzycka-Guttman T. The activity of Selol in multidrug-resistant and sensitive human leukemia cells. Oncology Reports. 2007;18(4):893-899.
  444. Pawiński T, Durlik M, Szlaska I, Urbanowicz A, Ostrowska J, Gralak B, Majchrzak J. The Weight of Pharmacokinetic Parameters for Mycophenolic Acid in Prediction of Rejection Outcome: The Receiver Operating Characteristic Curve Analysis. Transplantation Proceedings. 2006;38(1):86-89.
  445. Świąder M, Łuszczki J, PARUSZEWSKI R, Czuczwar S, Turski W. Anticonvulsant and acute neurotoxic characteristics of nicotinic acid benzylamide: a preclinical study. Pharmacological Reports. 2006;58(3):431-434.
  446. Pawiński T, Durlik M, Szlaska I, Urbanowicz A, Majchrzak J, Gralak B. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant. Journal of Clinical Pharmacy and Therapeutics. 2006;31(1):27-34.
  447. Suchocka Z, Swatowska J, Pachecka J, Suchocki P. RP-HPLC determination of paraoxonase 3 activity in human blood serum. Journal of Pharmaceutical and Biomedical Analysis. 2006;42(1):113-119.
  448. Grudzień M, Pluciński F, Mazurek A. Molecular Properties of Econazole and Sulconazole Relevant to Bioavailability. Acta Poloniae Pharmaceutica - Drug Research. 2006;62(5):465-466.
  449. Dąbrowski R, Sadowski Z, Goldnik H, Marszałek D, Kunicki P, (...), Szwed H. Wyższa skuteczność doraźnego podania nitrendypiny drogą doustną w porównaniu z drogą podjęzykową. Ocena farmakokinetyczna i farmakodynamiczna u chorych ze wzrostem ciśnienia tętniczego. Nadciśnienie Tętnicze. 2005;9(3):168-177.
  450. Paruszewski R, Strupińska M, Rostafińska-Suchar G, Stables J. New derivatives of picolinic acid and nicotinic acid with anticonvulsant activity.. Protein and Peptide Letters. 2005;12(7):701-704.
  451. Szypuła W, Pietrosiuk A, Suchocki P, Olszowska O, Furmanowa M, Kazimierska O. Somatic embryogenesis and in vitro culture of Huperzia selago shoots as a potential source of huperzine A. Plant Science. 2005;168(6):1443-1452.
  452. Pawiński T, Gralak B. HPLC determination of active metabolite of Leflunomide in plasma. Chemia Analityczna. 2005;50(4):785-793.
  453. Paruszewski R, Jaworski P, Bodnar-Broniarczyk M, Dudkiewicz-Wilczyńska J, Roman I. New renin inhibitors containing pseudodipeptidic units in P3-P2 and P1-P1' positions. Chemical and Pharmaceutical Bulletin. 2005;53(10):1305-1309.
  454. Wasek M, Wyszkowski M. The assurance and maintenance of the quality system in laboratory of personal and environmental doses for radiological protection. CLOR Report. 2004:83-84.
  455. Wasek M, Wyszkowski M. Occupation exposure to external radiation monitored by CLOR in 2004-2005. CLOR Report. 2004:68-69.
  456. Pawiński T, Shaw L. Stability of mycophenolic acid in plasma samples from patients during mycophenolate mofetii therapy. Acta Poloniae Pharmaceutica - Drug Research. 2003;60(2):121-124.
  457. Paruszewski R, Strupińska M, Stables J, Swiader M, Czuczwar S, Kleinrok Z, Turski W. Amino acid derivatives with anticonvulsant activity. Chemical and Pharmaceutical Bulletin. 2001;49(5):629-631.
  458. Wysocka-Paruszewska B, Brzeziński J, Krajewska-Brzywczy G, Szutowski M. Influence of thiram pretreatment on effects following intoxication of rats with fenitrothion. Acta Poloniae Toxicologica. 2000;8(2):277-290.
  459. Pawiński T, Gajewska M. Determination of Azathioprine, Prednisone and Methylprednisolone in Human Blood Serum by High Performance Liquid Chromatography. Chemia Analityczna. 1997;42(2):233-238.
  460. Gajewska M, Pawiński T, Dzierzgowska-Szmidt A, Grieb P, Ryba M. Determination of 2-bromo and 2-chloro derivatives of 2'-deoxyadenosine in human blood serum by high performance liquid chromatography. Acta Poloniae Pharmaceutica - Drug Research. 1994;51(2):109-114.
  461. Gajewska M, Dzierzgowska A, Pawiński T, Czerwińska K. Spectrofluorimetric assay of azathioprine and 6-mercaptopurine in human blood plasma. Acta Poloniae Pharmaceutica - Drug Research. 1992;49(4):13-16.
  462. Kocur A, Szlaska I, Pirianowicz-Chaber E, Strupińska M, Pawiński T, Franczak-Rogowska M, Winiecka I, Marszałek D, Bodnar-Broniarczyk M. Oznaczanie substancji leczniczych w preparatach wieloskładnikowych. Wyd. I. Praca zbiorowa pod red. Pawiński T [redaktor]. Warszawa: Warszawski Uniwersytet Medyczny, 2024. ISBN: 978-83-7637-637-0.
  463. Kocur A, Pawiński T, Marszałek D, Szlaska I, Strupińska M, Bodnar-Broniarczyk M, Franczak-Rogowska M, Winiecka I, Pirianowicz-Chaber E. Oznaczanie ilościowe substancji leczniczych, z zastosowaniem analizy miareczkowej, w preparatach jednoskładnikowych w postaci tabletek, drażetek i kapsułek. Wyd. I. Praca zbiorowa pod red. Pawiński T [redaktor]. Warszawa: Warszawski Uniwersytet Medyczny, 2023. ISBN: 978-83-7637-619-6.
  464. Novel strategies in the development of new therapies, drug substances and drug carriers 2.0. Wyd. I. Praca zbiorowa pod red. Kallay E [redaktor], Kutner A [redaktor], Brown G [redaktor]. Basel, Beijing, Wuhan, Barcelona, Belgrade, Manchester, Tokyo, Cluj, Tianjin: MDPI, 2023. ISBN: 978-3-0365-8657-1.
  465. Novel strategies in the development of new therapies, drug substances and drug carriers. Wyd. I. Praca zbiorowa pod red. Kallay E [redaktor], Kutner A [redaktor], Brown G [redaktor]. Basel, Beijing, Wuhan, Barcelona, Belgrade, Manchester, Tokyo, Cluj, Tianjin: MDPI, 2022. ISBN: 978-3-0365-4645-2.
  466. Winiecka I, Szlaska I, Pawiński T, Jaworski P, Pirianowicz-Chaber E, Strupińska M, Żero P, Grudzień M, Somogi A, Goldnik A, Rostafińska-Suchar G, Bodnar-Broniarczyk M, Marszałek D. Metody ilościowego oznaczania środków leczniczych. Wyd. I. Praca zbiorowa pod red. Pawiński T [redaktor]. Warszawa: Warszawski Uniwersytet Medyczny, 2020. ISBN: 978-83-7637-540-3.
  467. Grudzień M, Pirianowicz-Chaber E, Bodnar-Broniarczyk M, Strupińska M, Marszałek D, Jaworski P, Winiecka I, Pawiński T, Somogi A, Szlaska I, Goldnik A, Dzierzgowska-Szmidt A, Rostafińska-Suchar G. Metody oceny jakościowej leków w analizie farmaceutycznej : skrypt do ćwiczeń z Chemii Leków. Wyd. I. Praca zbiorowa pod red. Pawiński T [redaktor]. Warszawa: Oficyna Wydawnicza Warszawskiego Uniwersytetu Medycznego, 2016. ISBN: 978-83-7637-402-4.
  468. Strupińska M, Żero P, Bodnar-Broniarczyk M, Jaworski P, Winiecka I, Grudzień M, Somogi A, Goldnik A, Marszałek D, Pawiński T, Rostafińska-Suchar G, Szlaska I, Pirianowicz-Chaber E. Analiza ilościowa środków leczniczych : skrypt do ćwiczeń z Chemii leków. Cz. 1. Wyd. I. Praca zbiorowa pod red. Pawiński T [redaktor]. Warszawa: Oficyna Wydawnicza Warszawskiego Uniwersytetu Medycznego, 2015. ISBN: 978-83-7637-349-2.
  469. Jaworski P, Rostafińska-Suchar G, Szlaska I, Pirianowicz-Chaber E, Strupińska M, Grudzień M, Marszałek D, Bodnar-Broniarczyk M, Żero P, Winiecka I, Pawiński T, Somogi A, Goldnik A. Analiza ilościowa środków leczniczych : skrypt do ćwiczeń z Chemii leków. Cz. 2. Wyd. I. Praca zbiorowa pod red. Pawiński T [redaktor]. Warszawa: Oficyna Wydawnicza Warszawskiego Uniwersytetu Medycznego, 2015. ISBN: 978-83-7637-350-8.
  470. Dzierzgowska-Szmidt A, Grudzień M, Somogi A, Strupińska M, Szlaska I, Pawiński T, Winiecka I, Jaworski P, Rostafińska-Suchar G, Pirianowicz-Chaber E, Goldnik A, Bodnar-Broniarczyk M, Marszałek D. Analiza jakościowa środków leczniczych : skrypt do ćwiczeń z Chemii Leków. Wyd. I. Praca zbiorowa pod red. Pawiński T [redaktor]. Warszawa: Oficyna Wydawnicza Warszawskiego Uniwersytetu Medycznego, 2014. ISBN: 978-83-7637-251-8.
  471. Lisowska-Myjak B, Zborowska H, Białek S, Wroczyński P, Kuch M, Skarżyńska E. Analysing Thyroid Hormone Profiles and Serum Proteins in Healthy Young Women in the Preconception Period and their Relationship with Anthropometric Parameters. W: Achievements and Challenges of Medicine and Medical Science Vol. 1. Wyd. I. Praca zbiorowa pod red. Unver Saraydin S [redaktor]. BP International, 2024. ISBN: 978-93-48388-84-1. Str. 40-55.
  472. Franczak-Rogowska M, Szeleszczuk Ł, Kolmas J. Projekt DOMINOS - nowe podejście do egzaminów OSCE. W: W poszukiwaniu doskonałości dydaktycznej. Wyd. I. Praca zbiorowa pod red. Macijowska I [redaktor naukowy], Sajdak-Burska A [redaktor naukowy]. Kraków: Wydawnictwo Uniwersytetu Jagiellońskiego, 2024. ISBN: 978-83-233-5434-5. Str. 239-250.
  473. Żołek T, Yasuda K, Brown G, Sakaki T, Kutner A. In silico prediction of the Metabolic resistance of vitamin D analogs against CYP3A4 Metabolizing Enzyme. W: Novel strategies in the development of new therapies, drug substances and drug carriers 2.0. Wyd. I. Praca zbiorowa pod red. Kallay E [redaktor], Kutner A [redaktor], Brown G [redaktor]. Basel, Beijing, Wuhan, Barcelona, Belgrade, Manchester, Tokyo, Cluj, Tianjin: MDPI, 2023. ISBN: 978-3-0365-8657-1. Str. 183-196.
  474. Kowalski K, Kalicka A. Zastosowanie przenośnych urządzeń do wykonywania i identyfikacji zagrożeń ze strony sfałszowanych leków, substancji psychoaktywnych, narkotyków i materiałów wybuchowych. W: Przestępczość farmaceutyczna w III dekadzie XXI wieku - pandemia, kryzys, konflikty zbrojne - zagrożenia i konsekwencje : VII Międzynarodowa Konferencja Naukowo-Szkoleniowa : materiały konferencyjne. Wyd. I. Praca zbiorowa pod red. Fijałek Z [redaktor naukowy]. Kraków: Uniwersytet Jagielloński Collegium Medicum Wydział Farmaceutyczny, 2022. ISBN: 978-83-959554-7-1. Str. 119-130.
  475. Kalicka A, Fijałek Z. Profilowanie sfałszowanych i nielegalnych produktów leczniczych. W: Przestępczość farmaceutyczna w III dekadzie XXI wieku - pandemia, kryzys, konflikty zbrojne - zagrożenia i konsekwencje : VII Międzynarodowa Konferencja Naukowo-Szkoleniowa : materiały konferencyjne. Wyd. I. Praca zbiorowa pod red. Fijałek Z [redaktor naukowy]. Kraków: Uniwersytet Jagielloński Collegium Medicum Wydział Farmaceutyczny, 2022. ISBN: 978-83-959554-7-1. Str. 117-118.
  476. Kalicka A, Stępień K. Zastosowanie metody LC-MS/MS do identyfikacji substancji czynnych w sfałszowanych i nielegalnych produktach leczniczych. W: Przestępczość farmaceutyczna w okresie pandemii COVID-19. Wyd. I. Praca zbiorowa pod red. Pokrywka A [redaktor], Skibińska B [redaktor]. Warszawa: ZOZ Ośrodek UMEA SHINODA-KURACEJO, 2021. ISBN: 978-83-959554-1-9. Str. 55-59.
  477. Fijałek Z, Kalicka A. Przestępczość farmaceutyczna a doping. W: Doping w sporcie. Wyd. I. Praca zbiorowa pod red. Mamcarz A [redaktor naukowy], Bujalska-Zadrożny M [redaktor naukowy], Pokrywka A [redaktor naukowy]. Warszawa: Wydawnictwo Lekarskie PZWL, 2020. ISBN: 978-83-200-5919-9. Str. 451-468.
  478. Giebułtowicz J, Kucharski D, Drzewicz P. Soil and sediment analysis. W: Green sustainable process for chemical and environmental engineering and science. Wyd. I. Praca zbiorowa pod red. Boddula R [redaktor], Asiri A [redaktor], Inamuddin D [redaktor]. Amsterdam: Elsevier, 2020. ISBN: 978-0-12-821883-9. Str. 85-116.
  479. Fijałek Z, Kalicka A. Sfałszowane leki – zagrożenia dla pacjentów i rola farmaceuty w zabezpieczeniu legalnej sieci dystrybucji. W: Jakość leków a przestępstwa farmaceutyczne - zagrożenia dla zdrowia. Wyd. I. Praca zbiorowa pod red. Opoka W [redaktor], Skibińska B [redaktor naukowy], Fijałek Z [konsultant naukowy]. Warszawa: Wydział Farmaceutyczny, Warszawski Uniwersytet Medyczny, 2019. ISBN: 978-83-946124-9-8. Str. 19-27.
  480. Stępień K. Wybrane aspekty jakości suplementów diety. W: Jakość leków a przestępstwa farmaceutyczne - zagrożenia dla zdrowia. Wyd. I. Praca zbiorowa pod red. Opoka W [redaktor], Skibińska B [redaktor naukowy], Fijałek Z [konsultant naukowy]. Warszawa: Wydział Farmaceutyczny, Warszawski Uniwersytet Medyczny, 2019. ISBN: 978-83-946124-9-8. Str. 111-115.
  481. Pawiński T. Terapeutyczne monitorowanie stężeniem leku - farmacja w służbie optymalizacji leczenia pacjentów. W: Kierunki rozwoju chemii leków : Księga Jubileuszowa Profesor Marianny Zając. Wyd. I. Praca zbiorowa pod red. Jelińska A [redaktor], Muszalska I [redaktor]. Poznań: Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, 2017. ISBN: 978-83-7597-312-9. Str. 180-186.
  482. Błazewicz A, Popławska M, Warowna-Grześkiewicz M, Sarna K, Fijałek Z. Determination of Quaternary Ammonium Muscle Relaxants with Their Impurities in Pharmaceutical Preparations by LC-CAD. W: Charged Aerosol Detection for Liquid Chromatography and Related Separation Techniques. Wyd. I. Praca zbiorowa pod red. Gamache P [redaktor]. USA: John Wiley & Sons, 2017. ISBN: 9780470937785. Str. 425-448.
  483. Chomicz L, Starościak B, Dybicz M, Chruścikowska A, Baltaza W, Pilich I, Perkowski K, (...), Zawadzki P, Padzik M, Wroczyński P. The role of developmental stages of Plodia interpunctella (Arthropoda, Insecta) as reservoirs/vectors of pathogenic fungi distributed in the human environment. W: Stawonogi we współczesnym świecie. Wyd. I. Praca zbiorowa pod red. Buczek A [redaktor], Błaszak C [redaktor]. Lublin: KOLIBER, 2015. ISBN: 978-83-60497-03-6. Str. 327-333.
  484. Nahorski W, Chomicz L, Biernat B, Szostakowska B, Wroczyński P. A vector control as intervention tool in arthropod-born dengue virus (DENV) infection in humans. W: Stawonogi : zagrożenie zdrowia człowieka i zwierząt. Wyd. I. Praca zbiorowa pod red. Błaszak C [redaktor], Buczek A [redaktor]. Lublin: KOLIBER, 2014. ISBN: 978-83-60497-87-6. Str. 85-92.
  485. Łuszczyńska P, Wyzgał P, Czaplicka K, Pawiński T. Opracowanie i walidacja metody oznaczania wolnej frakcji kwasu mykofenolowego w osoczu krwi ludzkiej z zastosowaniem chromatografii cieczowej połączonej z tandemową detekcją masową (LC-MS/MS). W: X Konferencja Chromatograficzna „Chromatografia – niezbędne narzędzie w nauce i technice”, Lublin, 23-26 września 2014 r. Książka abstraktów. Wyd. I. Lublin: Katedra i Zakład Chemii Leków, Wydział Farmaceutyczny z Oddziałem Analityki Medycznej, Uniwersytet Medyczny w Lublinie, 2014. Str. 85-86.
  486. Giebułtowicz J. Aktywność dehydrogenazy aldehydowej klasy trzeciej ALDH3A1 w stanie fizjologicznym oraz nowotworach i torbielach jamy ustnej. W: Zastosowania metod statystycznych w badaniach naukowych IV. Wyd. I. Praca zbiorowa pod red. Wątroba J [redaktor naukowy], Jakubowski J [redaktor naukowy]. Kraków: StatSoft Polska, 2012. ISBN: 978-83-88724-64-0 . Str. 19-28.
  487. Pawiński T. Znaczenie parametrów farmakokinetycznych w optymalizacji terapii immunosupresyjnej. W: Blaski i cienie immunoterapii. Immunologiczne aspekty transplantologiii i leczenia wspomagającego. Wyd. I. Praca zbiorowa pod red. Niewiński P [redaktor], Hurkacz M [redaktor], Wiela-Hojeńska A [redaktor]. Warszawa: Wydawnictwo Consort, 2009. ISBN: 978-83-928499-0-2. Str. 5-26.